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ZUSAMMENFASSUNG 
Stammzellen der adulten Skelettmuskulatur, auch als Satellitenzellen bekannt, 
befinden sich normalerweise in einem Ruhezustand und können als Reaktion auf 
bestimmte Reize aktiviert werden und differenzieren. Durch diese Aktivierung werden 
Muskelintegrität und –regeneration gesteuert. Störungen der Satellitenzell-
Homöostase werden mit Pathologien einiger humaner Muskelerkrankungen in 
Verbindung gebracht. 
   Satellitenzellen, die durch die Expression des Transkriptionsfaktors Pax7 
identifiziert werden (Pax7+), stammen von stark proliferierenden Pax7+/MyoD+-
Vorläuferzellen ab, die während der embryonalen Entwicklung gebildet. Es konnte 
bereits gezeigt werden, dass Satellitenzellen eine andere chromatinorganisation als 
Vorläuferzellen beziehungsweise terminal differenzierte Nachkommen Unterschiede 
besitzen. Dies deutet darauf hin, dass epigenetische Regulatoren in der Zelle an der 
Schicksalsfindung und Zellidentitätskontrolle ursächlich beteiligt sein könnten, 
genauere Mechanismen sind bisher nicht bekannt. Durch meine durchgeführten 
Experimente konnte ich zeigen, dass die Protein-Arginin-Methyltransferase 5 
(PRMT5)-ein epigenetischer Modifizierer, der die symmetrische H3R8 
Dimethylierung (H3R8me2) in Nukleosomen katalysiert - einen wesentlichen Faktor 
für Pax7+ Satelliten-Zell-Homöostase bei erwachsenen Skelettmuskel darstellt, 
Andererseits spielt PRMT5 keine Rolle bei der Pax7+ Muskelvorläuferzellproliferation 
und Differenzierung während der Entwicklung ist. 
   Im adulten ruhenden Muskel wird PRMT5 ruhenden Satellitenzellen stark 
exprimiert. Induzierte Deletion des PRMT5-Gens in Pax7+ Satellitenzellen führt nicht 
nur zu einem massiven Rückgang der Anzahl der Muskel-Stammzellen während der 
Alterung, sondern verhindert die Muskelregeneration nach einer akuten 
Muskelverletzung. Auf zellulärer Ebene ist PRMT5 für Satellitenzellproliferation, 
während dem frühen Stadium der Zelldifferenzierung und dem Zellüberleben bei Ex-
vivo-Differenzierung erforderlich. PRMT5 bindet direkt an die p53-Bindungsstelle am 
Gen-Locus des Zellzyklusinhibitors p21 und induziert ein epigenetisches Gen-
Silencing durch Anreicherung von H3R8me2s, Was zu eine Arretierung der 
Satellitenzellproliferation führt. Damit übereinstimmend, konnte durch die genetische 
Deletion von p21 die beobachtete, verminderte Proliferation von PRMT5-negativen 
Satellitenzellen wiederhergestellt werden. Wird PRMT5 in aus Pax7+ Satellitenzellen 
abgeleiteten differenzierten Myotuben durch induzierte Ablation entfernt, so können 
diese Mäuse nach Muskelschädigung die Muskelfasern regenerieren. Diese 
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Regenerationsfähigkeit ist mit der Wildtyp-Situation vergleichbar und so kann davon 
ausgegangen werden, dass PRMT5 in differenzierten Myotuben keine signifikante 
Rolle spielt. 
   Der genetische Verlust von PRMT5 in Pax7-Vorläuferzellen während der 
embryonalen Entwicklung führt weder zu Veränderungen der Vermehrung noch der 
Differenzierung dieser Vorläuferzellen, so dass die These unterstützt wird, dass 
PRMT5 in der Expansion von Skelettmuskulatur-Vorläuferzellen und der Myotom-
Bildung während der Entwicklung keine essentielle Funktion ausübt. Die erzielten 
Ergebnisse weisen eine einzigartige und essentielle Funktion von PRMT5 in der 
Satellitenzell-Homöostase nach und zeigen, dass PRMT5 in embryonale Muskel-
Vorläuferzellen und differenzierten Muskelzellen keine wichtige Rolle spielt. Hieraus 
ergibt sich, dass die embryonale Muskelentwicklung und die adulte Myogenese auf 
unterschiedlichen Regulationsmechanismen basieren. 
   In weiteren Experimenten konnte ich eine zentrale Rolle von PRMT5 in der 
Steuerung der regenerativen Myogenese bei Muskel Dystrophien nachweisen. MDX-
Mäuse, die ebenso wie humanen Duchenne-Muskledystrophie (DMD) Patienten, 
nicht das Dystrophin-Protein Expression, wurde mittels induzierter Deletion PRMT5 
in Satellitenzellen entfernt. Dies resultierte in einer kompletten Depletion der Muskel-
Stammzell-Population, einem dramatischen Verlust von Muskelmasse und einer 
erhöhten Muskelfibrose, was verschiedene symptome  der humanen DMD nur 4 
Monaten nach Induktion des PRMT5-Verlustes rekapituliert. Meine Ergebnisse 
zeigen, dass PRMT5 ein mögliches Target für die Behandlung der humanen DMD 
hat. Weitere Studien sind nötig, um die Rolle von PRMT5 in der humanen DMD zu 
verstehen. 
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SUMMARY 
Adult skeletal muscle stem cells known as satellite cells are normally maintained in a 
quiescent state and could activate, differentiate in responding to environmental cues 
thereby being responsible for muscle integrity and regeneration in the lifetime. 
Deregulation satellite cell homeostasis has been implicated in the pathology of 
several human muscle diseases. Satellite cells that are identified by the expression 
of transcription factor Pax7 (Pax7+) originate from highly proliferative Pax7+/MyoD+ 
progenitor cells during development. Interestingly it has been demonstrated that 
satellite cells show a chromatin organization which is different from the 
corresponding precursors or terminally differentiated progenies suggesting that 
epigenetic regulators might be causally involved in cell fate determination and cell 
identity control. In this study I demonstrated that the protein arginine 
methyltransferase 5 (PRMT5), an epigenetic modifier catalyzes symmetric H3R8 
dimethylation (H3R8me2) in nucleosomes, is an essential factor for Pax7+ satellite 
cell homeostasis in adult skeletal muscle. In contrast, PRMT5 is not required for 
Pax7+ muscle progenitor cell proliferation and differentiation during development and 
the function of differentiated myotubes in adult skeletal muscle.  
   In adult resting muscle, PRMT5 is highly expressed in quiescent satellite cells. 
Induced deletion of PRMT5 in Pax7+ satellite cells does not only lead to a massive 
decline of the number of muscle stem cells during aging, but also completely 
abolishes muscle regeneration after acute muscle injury. At the cellular level, PRMT5 
is required for satellite cell proliferation, early stage of cell differentiation and cell 
survival upon differentiation ex vivo. Mechanistically PRMT5 directly binds to the p53 
binding site at the locus of cell cycle inhibitor p21 gene and induces epigenetic gene 
silencing by depositing H3R8me2s. The up-regulation of p21 in Prmt5 mutant 
satellite cells results in an arrest of satellite cell proliferation. Consistently, genetic 
loss of p21 partially restores the proliferation defects of PRMT5 deficient satellite 
cells. Importantly, mice with induced ablation of PRMT5 in Pax7+ satellite cell derived 
differentiated myocytes regenerate skeletal muscle to the same degree wild type 
mice, suggesting that PRMT5 is dispensable in differentiated myofibers. Furthermore, 
ablation of PRMT5 in Pax7+ precursors during embryonic development does not alter 
the precursor cell proliferation and differentiation, indicating that PRMT5 is 
dispensable for expansion of skeletal muscle progenitor cells and formation of 
muscle cells during development. Taken together these findings demonstrate a 
unique and essential role of PRMT5 in satellite cell homeostasis suggesting distinct 
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genetic and epigenetic requirements for developmental myogenesis and regenerative 
myogenesis.   
   In addition, I analyzed the role of PRMT5 in muscle regeneration in a murine model 
of muscular dystrophy. Induced satellite cell specific deletion of PRMT5 in mdx mice, 
a model lacking dystrophin expression as that in human  Muscular Dystrophy (DMD) 
patients but showing much less severe and representative muscle phenotypes, 
results in depletion of the muscle stem cell pool, dramatic loss of muscle mass and 
increase of muscle fibrosis, recapitulating many pathological features of human DMD 
patients in only 4 months after PRMT5 ablation. This finding demonstrated that 
PRMT5 mediated epigenetic regulation of regenerative myogenesis has therapeutic 
implications for human DMD. Further studies will focus on detailed 
pathophysiological analyses of PRMT5 and mdx double mutant mice and the role of 
PRMT5 in human DMD.   
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1 INTRODUCTION 
Skeletal muscle is the most abundant tissue in the vertebrate body and plays a major 
role in physiological functions such as locomotion, breathing and energy 
metabolism. The structural units of skeletal muscle are muscle fibers or myofibers, 
formation of which is defined as myogenesis. In mammals myogenesis includes 
developmental and adult regenerative myogenesis. Developmental myogenesis 
refers to muscle fiber formation during embryonic development, which could be 
further separated into two stages: embryonic myogenesis and fetal myogenesis 
(Messina and Cossu, 2009) . Embryonic myogenesis begins with myotome formation 
at E9.5 followed by fusion of myoblasts and formation of primary (embryonic) fibers 
at approximately day E11.5. Fetal myogenesis starts with the proliferating myoblasts 
that do not fuse into primary fibers but continue to proliferate and differentiate only at 
E14.5–17.5 giving rise to secondary (fetal) fibers (Buckingham and Rigby, 2014; 
Messina and Cossu, 2009). In the mouse fetal myogenesis is complete three weeks 
after birth and further muscle mass increase depends on hypertrophic muscle growth 
without dramatic proliferation of myoblast cells (White et al., 2010). Adult skeletal 
muscle is a tissue with high potential for regeneration to repair muscle damage after 
physiological and non-physiological muscle injury. Regenerative myogenesis is 
defined as the formation of new muscle after muscle injury in adult stage. This largely 
relies on adult muscle stem cells termed satellite cells, which are derived from the 
muscle progenitor cells during embryonic muscle development (Yin et al., 2013b).  
1.1 Developmental myogenesis 
Developmental myogenesis of trunk and limb muscles is initiated in the somites, 
segmented structures that form from paraxial mesoderm in an anterior-to-posterior 
manner. The dorsal epithelial region of the maturing somite, the dermomyotome, 
gives rise to muscle progenitor cells as well as other tissue progenitors developing 
into endothelial and smooth muscle cells of blood vessels, dermal and brown fat 
lineages. Muscle progenitor cells within dermomyotome proliferate, differentiate and 
produce mononucleated myoblasts. At around embryonic day 11 (E11), these 
postmitotic mononucleated myoblasts start to migrate out from the border regions of 
the dermomyotome, fusion into multinucleate muscle fibers in the mouse that 
characterizes “embryonic” or primary myogenesis necessary to establish the basic 
muscle pattern. 
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1.1.1 Pax3 is involved in the control of embryonic myogenesis  
The formation of muscle during early embryonic development depends on the 
proliferation, differentiation and migration of muscle progenitor cells, which is tightly 
regulated by a myogenic transcription factor network including Pax3, Myf5, MyoD 
and Mrf4. While myogenic transcription factor Myf5 and Mrf4 play a critical role in 
myogenic progenitors in somites (Braun and Gautel, 2011; Tajbakhsh et al., 1996), 
Pax3, the paired homeobox containing transcription factor controls cell survival 
particularly  in the hypaxial domain of the somite (Franz et al., 1993; Goulding et al., 
1994). Additionally Pax3 marks migrating myogenic progenitor cells that have not yet 
activated the myogenic determination genes(Bober et al., 1994). Once Pax3-positive 
myogenic cells have left the dermomyotome and started to form muscle mass, a 
critical cellular equilibrium has to be maintained between self-renewal of the 
progenitor pool and embryonic myofiber formation (Buckingham and Rigby, 2014). 
This could be regulated by FGF signaling pathway. Pax3 directly controls a myogenic 
enhancer element of Fgfr4 and activates its expression, which promotes progenitors 
entry into the differentiation program (Lagha et al., 2008). After entering into the 
myogenic program, Pax3 activates the transcription of myogenic factor Myf5 leading 
to the activation of other down-stream transcription factors for instance MyoD and 
Myogenin by regulating its enhancer elements as well (Chang et al., 2004; Francetic 
and Li, 2011; Tajbakhsh et al., 1997). Therefore Pax3 is critical for controlling 
embryonic myogenesis by regulating the cellular equilibrium of self-renewal of 
muscle progenitor cells and myogenic cell differentiation.  
1.1.2 Pax7 maintains skeletal muscle stem cells 
As muscle development proceeds, the second wave of myogenesis (also called fetal 
myogenesis) takes place between E14.5 and E17.5 in the mouse and involves the 
fusion of secondary myoblasts either with each other to form secondary fibers 
(initially smaller primary fibers) or with primary myofibers. Fetal myogenesis is 
characterized by growth and maturation of each muscle anlagen and by the onset of 
innervation (Messina and Cossu, 2009). While Pax3 transcription is down-regulated 
in fetal muscle with a notable exception being the persistence of Pax3 expression in 
a subset of satellite cells including those residing in the diaphragm (Relaix et al., 
2006), Pax7, a paralog of Pax3, becomes the dominant factor in all myogenic 
progenitor cells. In the limb, Pax7 is initially co-expressed with Pax3. Genetic tracing 
experiments showed that all later Pax7-positive cells in the fetal limb are derived from 
cells that had expressed Pax3 (Hutcheson et al., 2009). Pax7 activates the 
transcription factor nuclear factor 1/X (Nfix) that in turn, activates fetal specific genes, 
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including muscle creatine kinase (MCK) and β-enolase, while repressing embryonic 
genes, such as slow myosin (Messina et al., 2010). The loss of fetal myofibers when 
the Pax7 lineage is ablated highlights the important role of Pax7+ cells for fetal 
myogenesis. In late-stage of fetal muscle development, the Pax3 derived Pax7 
positive cells begin to adopt a satellite cell position (Kassar-Duchossoy et al., 2005; 
Relaix et al., 2005), suggesting that this somite-derived population also provides the 
progenitor cells for postnatal skeletal muscle (Gros et al., 2005). Therefore Pax3+ 
and Pax7+ cells contribute differentially to embryonic and fetal limb myogenesis 
respectively.  
 
 
 
1.1.3 Developmental myogenesis of head muscle 
Emerging evidence demonstrated that head muscle development follows a distinct 
program compared to limb/trunk muscle development. Initial specification of mouse 
masseter muscles depends on the bHLH genes MyoR and capsule without the need 
of Pax3 and Pax7 (Lu et al., 2002). The activation of myogenic program by these two 
transcription factors leads to formation of head muscle. Additional players are 
pituitary homeobox 2 (Pitx2) and T-box transcription factor 1 (Tbx1), both of which 
are expressed widely in the developing mouse embryo. Pitx2 mutants do not properly 
develop the muscles that are derived from the first branchial arch (Dong et al., 2006) 
and extraocular muscles due to extensive cell death in the premyogenic mesoderm 
Figure 1.1.1 Model of embryonic and fetal limb myogenesis (Messina and Cossu, 2009) 
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(Gage and Camper, 1997). Furthermore induced deletion of Pitx2 using UBC-
CreERT2 that avoids premyogenic mesoderm apoptosis down-regulates Myf5 and 
Mrf4 and abolishes the expression of MyoD, indicating that Pitx2 functions upstream 
of these myogenic factors during head muscle formation (Zacharias et al., 2011). 
Pitx2 directly activates Myf5 as well as MyoD through binding to the regulatory region 
at the promoter region. These findings suggest that Pitx2 regulates both progenitor 
cell survival and myogenic specification at the onset of extraocular muscle formation, 
mimicking the role of Pax3 at the sites of myogenesis in the body.  Tbx1 mutants also 
suffer from impaired myogenesis in the first branchial arch and lack the muscles that 
normally originate from other arches due to the severe malformations of these 
structures (Jerome and Papaioannou, 2001; Kelly et al., 2004). In Tbx1/Myf5 double 
mutants all muscles derived from the first branchial arch are absent suggesting that 
Tbx1 functions up-stream of MyoD as well(Sambasivan et al., 2009). Additionally 
Tbx1 mediated head muscle myogenesis has been linked to Fgf10 and Fgf8 
signaling cascade, ablation of which results in inhibition of proliferation of the 
myogenic progenitor cells (Ng et al., 2002).  
 
 
1.2 Regenerative myogenesis and muscle stem cells 
Unlike de novo embryonic muscle formation, regenerative myogenesis in higher 
vertebrates depends on both the injured tissue retaining an extracellular matrix 
scaffolding as a template for the formation of muscle fibers and the recruitment of an 
undifferentiated muscle stem cells also known as satellite cells (Ciciliot and 
Schiaffino, 2010). These stem cells have been shown to use asymmetric divisions for 
self-maintenance and, at the same time, giving rise to more committed myogenic 
progenies (Conboy et al., 2007; Kuang et al., 2007; Shinin et al., 2006).  
Figure 1.1.3 Gene regulatory network that governs myogenesis in the head and 
truck/limbs (Buckingham and Rigby, 2014) 
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1.2.1 Characteristics of satellite cells  
Skeletal muscle satellite cells are quiescent mononucleated myogenic cells residing 
between the basal lamina and the plasma membrane of the muscle fibers. Satellite 
cells could be morphologically distinguished from the fully differentiated myocyte by 1) 
a relatively high nuclear-to-cytoplasmic ratio with few organelles; 2) a smaller nuclear 
size compared with the adjacent nucleus of the myotube; and 3) an increase in the 
amount of nuclear condensed heterochromatin compared with that of the 
myonucleus (Figure 1.2.1). 
 
 
 
 
  Studies from immunohistochemical staining, genetic profiling and mouse transgenic 
studies have further revealed molecular and cellular markers that can be used to 
distinguish satellite cells from other cell types. Among them, the most widely 
accepted markers are CD34, CXCR-4, M-cadherin, Pax7, syndecan-3, syndecan-4, 
α7-intergin and c-met  (Alfaro et al., 2011; Burkin and Kaufman, 1999; Cornelison et 
al., 2001; Cornelison and Wold, 1997; Ratajczak et al., 2003; Seale et al., 2000). 
While many of these defined cell markers expressed in satellite cells are not unique 
to this stem cell population, combination of these markers can be used to isolate pure 
Figure 1.2.1 Characteristics of muscle satellite cells in the myofibers 
Satellite cells occupy a sub-laminar position in adult skeletal muscle. The satellite cells can be 
distinguished from the myonuclei by a surrounding basal lamina and more abundant 
heterochromatin as shown by electron micrograph picture (Hawke and Garry, 2001). Bar = 1 
μm. 
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satellite cells from skeletal muscle (Fukada et al., 2004; Montarras et al., 2005; 
Pannerec et al., 2012; Zammit et al., 2006).  
1.2.2 Origins of satellite cells 
Satellite cells originate from Pax3 and Pax7 expressing cells which initially are 
derived from the dermomyotome (Relaix et al., 2005; Seale et al., 2000). Along this 
line inactivation of Pax7 results in severe depletion of muscle stem cells in adult 
stage and impaired muscle regeneration upon  injury (Gunther et al., 2013; Seale et 
al., 2000). Furthermore by using MyoDiCre/+/R26R-EYFP lineage tracing system 
Kanisicak and colleagues have shown that almost all satellite cells in adult muscle 
have activated MyoD during satellite cell development even though myoD expression 
is shut down in most adult satellite cells (Kanisicak et al., 2009). These results 
strongly support the idea that the majority of adult Pax7+ satellite cells have a somite 
origin and transit through a Pax7+/MyoD+ state. Inactivation of Pax7 in Myf5 positive 
lineage using Myf5Cre/+/Pax7loxP/loxP mice revealed that the majority of adult satellite 
cells originates from Myf5-expressing myogenic cells as well (Gunther et al., 2013). 
Consistently using a Myf5Cre/Rosa26YFP reporter, Kuang et al could show that the 
majority (90%) of the adult satellite cell pool originates from Myf5+ precursors (Kuang 
et al., 2007). Notably formation of the satellite cell pool in germline Myf5 or MyoD 
nulls suggests that Myf5 or MyoD is not required for satellite cell formation most likely 
due to the compensatory effect of Myf5 and MyoD during skeletal muscle 
development (Gensch et al., 2008; Haldar et al., 2008). 
   On the other hand, accumulating evidence also indicates that some adult satellite 
cells may have alternative origins other than dermomyotome-derived Pax3+/Pax7+ 
progenitors. For instance studies utilizing TN-APCreERT2 and VE-cadherinCreERT2 
alleles have showed that alkaline phosphatase (ALPL) expressing pericytes, but not 
VE-cadherin-expressing endothelial cells, can develop into postnatal satellite cells 
and participate in normal development of limb muscles (Dellavalle et al., 2011). 
Additionally multiple studies have demonstrated that several types of non-satellite 
cells can reconstitute the satellite cell niche and turn into bona fide satellite cells 
(Pax7-expressing myogenic cells) after transplantation into regenerating skeletal 
muscles. These cells include bone marrow-residing hematopoietic stem cell 
(LaBarge and Blau, 2002), CD45- muscle side population (SP) cells (Asakura et al., 
2002), PW1+ interstitial cells (Mitchell et al., 2010), Sca1+/CD34+ fibro-adiogenic 
progenitors (FAPs) (Joe et al., 2010b) and muscle derived stem cells (MDSCs) (Lee 
et al., 2000; Qu-Petersen et al., 2002). However, It remains largely unknown to what 
extent these cells contribute to the adult satellite cell pool and muscle regeneration 
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under physiological conditions, and the validity of some of these studies have been 
questioned. 
1.2.3 Satellite cells and adult muscle regeneration 
The main function of satellite cells is to regenerate muscle upon injury thereby 
maintaining muscle integrity in adulthood. Muscle regeneration occurs in three 
sequential but overlapping stages including myofiber necrosis; the inflammatory 
response; the activation, differentiation, and fusion of satellite cells; and the 
maturation and remodeling of newly formed myofibers. In intact muscle, satellite cells 
are sublaminal and mitotically quiescent. Upon exposure to signals from a damaged 
environment, satellite cells exit their quiescent state and start to proliferate (satellite 
cell activation) accompanied by the down-regulation of Pax7 and rapid activation of 
myogenic transcription factors: Myf5 and MyoD. These proliferating satellite cells and 
their progeny are often referred as adult myoblasts. Subsequent differentiation of 
myoblasts is marked by the up-regulation of Mrf4, Myogenin and myosin heavy chain 
(Zammit et al., 2004). Ultimately, these differentiated myoblasts form new 
multinucleated myofibers or fuse to the damaged myofibers resulting in muscle 
regeneration (Rudnicki et al., 2008). Some of the activated SCs that do not proliferate 
or differentiate maintain Pax7 gene expression but down-regulate MyoD expression. 
These cells eventually withdraw from the cell cycle and regain markers that 
characterize myogenic quiescence (Nagata et al., 2006). In essence, maintenance of 
satellite cell homeostasis is critical for the muscle regeneration both in physiological 
(e.g., extensive exercise) (Parise et al., 2008) and pathological conditions (e.g., 
myotoxin induced injury and degenerative diseases) (Lepper et al., 2011) by 
providing sufficient myoblasts for fusion and maintaining the quiescent satellite cell 
pool (Figure 1.2.3).  
  The necessary and sufficient role of satellite cells during muscle regeneration is 
clearly supported by the finding that ablation of the total satellite cell pool (all Pax7 
cells) in adulthood completely abolished muscle regeneration (Gunther et al., 2013; 
Sambasivan et al., 2011). However it has also been reported that several types of 
non-satellite cells can undergo myogenic differentiation and contribute to muscle 
regeneration after transplantation into regenerating muscle (Asakura et al., 2002; 
LaBarge and Blau, 2002; Mitchell et al., 2010; Polesskaya et al., 2003). Nevertheless, 
the contribution of these cells to adult muscle regeneration seems to be negligible 
compared with satellite cells, implying that the physiological relevance of non-satellite 
cell-based myogenesis might depend on Pax7 expression and/or the existence of 
considerable numbers of satellite cells.  
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1.3 Regulation of satellite cell homeostasis 
Satellite cells based adult muscle regeneration is highly orchestrated to ensure that 
specific genes are regulated in a temporally and spatially organized manner 
according to genetic and environmental factors (Dobreva and Braun, 2010; 
Yablonka-Reuveni et al., 2008). Regulation of satellite cell quiescence, activation, 
cell cycle re-entry and differentiation in response to muscle injury involve interplay of 
multiple muscle-specific transcription factors and epigenetic modifiers together with 
interaction with the satellite cell niche.   
1.3.1 Transcriptional regulation of satellite cell homeostasis 
The transcriptional network regulation satellite cell homeostasis has been well 
established. Pax7-mediated activation of MyoD and Myf5 specify a population of SCs 
that enters the differentiation program whereas Pax7+/MyoD- cells re-enter the 
quiescent state and replenish the satellite cell pool (Rudnicki et al., 2008). 
Furthermore down-regulation of Pax7 in Pax7+/MyoD+ or Pax7+/Myf5+ population 
coincides with the ability of MyoD and/or Myf5 to induce the transcription of 
downstream genes and promote terminal differentiation (Olguin and Pisconti, 2012). 
Consistently MyoD knockout mice show severely deficient skeletal muscle 
regeneration following injury due to excessive myoblast proliferation and defective 
differentiation of SCs (Cornelison et al., 2000). One of MyoD targets is the cyclin 
Figure 1.2.3 Schematic stages of satellite cell mediated myogenesis and markers 
typical for each stage (Zammit et al., 2006). 
INTRODUCTION 
 
9 
 
dependent kinase (CDK) inhibitor p21(waf1/Cip1), which is induced by MyoD during 
myoblast differentiation and subsequently permanent cell cycle arrest (Halevy et al., 
1995).   
   While Myf5 and MyoD are expressed in proliferating myoblasts prior to 
differentiation, Myogenin and MRF4 are only expressed in terminally differentiating 
cells (Megeney and Rudnicki, 1995). Expression of myogenin is primarily induced by 
MyoD, which enhances the expression of a subset of genes that are previously 
initiated by MyoD (Cao et al., 2006). Along this line ChIP-Seq analysis reveals a 
convoluted hierarchical gene expression circuitry centered on MyoD and its 
downstream targets: Myogenin and Mef2 transcription factors (Mef2s). Based on the 
temporal expression pattern of MyoD, Myogenin and Mef2s, a feed-forward 
regulatory circuit is proposed. In this hypothesis, myogenic differentiation is an 
irreversible procedure and is driven by the sequential expression of key transcription 
factors, which are destined to transduce gene expression signals to their target 
genes (Penn et al., 2004).  
1.3.2 Epigenetic regulation of satellite cell homeostasis 
Currently emerging evidence demonstrates that the epigenetic mechanisms 
contribute to the identity and homeostasis of satellite cells as well. Epigenetic 
circuitry is operated by highly interconnected events including post-translational 
modifications of histones (e.g. phosphorylation, acetylation, methylation and 
ubiquitination), chromatin remodeling, nucleosome patterning and DNA modifications. 
Specific chromatin states and epigenetic events have been shown to maintain the 
satellite cells homeostasis, and to enable the proper response to external cues 
(Dilworth and Blais, 2011; Giordani and Puri, 2013).  
   Histones undergo extensive post-translational modifications thereby influencing the 
chromatin structure as well as the interaction between DNA and nucleosomes 
leading to alteration of gene transcription. Histone acetylation has invariably been 
linked to transcriptional activation and is dynamically regulated by the opposing 
activities of histone acetyltransferases and histone deacetylases (HDAC) (Haberland 
et al., 2009). Two nuclear histone acetyltransferases, CREB-binding protein 
(CBP)/p300 and PCAF have been show to transactivate MyoD promoter by 
acetylating histone at Myod regulatory regions as well as MyoD itself  (Hamed et al., 
2013; Polesskaya et al., 2000). Three distinct classes of HDACs are involved in the 
repression of muscle gene transcription by countering the activities of histone 
acetyltransferases during myoblast proliferation (Lu et al., 2000; Mal et al., 2001; Puri 
et al., 2001). While class I HDACs could associate with and inhibit MyoD (Mal et al., 
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2001; Puri et al., 2001), class II HDACs (specifically HDAC4 and HDAC5) are 
dedicated repressors of MEF2 activity (Fulco et al., 2003; Lu et al., 2000; McKinsey 
et al., 2000a; McKinsey et al., 2000b). Class III HDACs, the NAD(+)-dependent 
histone deacetylase Sirt1, forms a repressor complex with PCAF and MyoD, 
silencing muscle gene expression in response to metabolic variations(Fulco et al., 
2003). 
   Histone methylation is another epigenetic means that has been shown to modulate 
the expression of muscle-specific transcriptional regulators at different stages of SCs. 
Genome wide epigenetic profiling in satellite cells revealed a fundamental role of 
H3K27me3 in suppressing factors associated with non-muscle lineages within a 
proliferative progenitor population (Woodhouse et al., 2013). Along with this, Liu et al 
demonstrated by ChIP-seq that quiescent SCs possess a permissive chromatin state 
in which only a few genes are epigenetically silenced by PcG-mediated H3K27me3 
whereas a large number of genes encoding regulators that specify non-myogenic 
lineages are demarcated by bivalent domains at their transcription start sites (TSSs) 
(Liu et al., 2013). For instance, a transition from a transcriptionally permissive 
H3K4me3 mark to a repressive H3K27me3 mark was observed on the Pax7 gene 
locus as proliferating myoblasts turn off this important marker of satellite cell identity 
and prepare for differentiation (Palacios et al., 2010). Consistently loss of Ezh2, the 
enzyme responsible for H3K27me3, in Pax7+ satellite cell leads to transcriptional 
deregulation in non-muscle lineages and impairs muscle stem cell expansion but not 
terminal differentiation (Juan et al., 2011; Woodhouse et al., 2013). Additionally 
TrxG/MLL complex that mediates H3K4 methylation in the Myf5 enhancer region has 
been shown to control satellite cell proliferation by interacting with Pax7 (McKinnell et 
al., 2008). 
   Chromatin-remodeling activities have been shown to play an essential role in the 
activation of muscle differentiation program, especially with the recruitment of the 
SWI/SNF complex to myogenic loci being of particular relevance (de la Serna et al., 
2006; Simone et al., 2004). Differentiation-activated p38α kinase phosphorylates 
BAF60c on a conserved threonine thereby promoting incorporation of MyoD–BAF60c 
into a Brg1-based SWI/SNF complex. The ATPase activity of Brg1 and Brm in the 
complex is essential for chromatin remodeling and active transcription of MyoD-target 
genes (de la Serna et al., 2006; Forcales et al., 2012; Simone et al., 2004).  
Furthermore, IGF1 signaling mediated local hyperacetylation at muscle genes by 
p300/CBP and PCAF HATs is required for the remodeling activity of the SWI/SNF 
complex (Serra et al., 2007), linking signaling transduction to chromatin remodeling in 
muscle gene expression. 
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   The condensed heterochromatin formation in satellite cells observed by electron 
microscope indicates that maintenance of high order chromatin structure is required 
for satellite cell identity. Differentiation of satellite cells into myocytes is accompanied 
with loss of condensed heterochromatin and formation of open euchromatin (Hawke 
and Garry, 2001). This suggests that epigenetic mechanisms regulating high order 
chromatin structure and/or controlling transition from heterochromatin to euchromatin 
are causally involved in regulating satellite cell homeostasis. It is tempting to propose 
that overall genome-wide alteration of DNA or histone modificationsin SCs will permit 
a full appreciation to what extent these complementary epigenetic marks modulate 
the myogenic gene expression program and SC homeostasis. 
1.3.3 Niche regulating satellite cell homeostasis 
Satellite cells are present in a highly specified niche, which consists of the 
extracellular matrix (ECM), vascular and neural networks, different types of 
surrounding cells, and various diffusible molecules. It has been shown that the 
dynamic interactions between satellite cells and their niche regulate satellite cell 
quiescence, self-renewal, proliferation, and differentiation by means of cell-cell 
interaction and autocrine or paracrine signals (Yin et al., 2013b).  
   The myofibers are the primary component of the satellite cell niche due to their 
direct contact with satellite cells. It has been proposed that the myofibers emanate a 
“quiescent” signal either by their physical association or by releasing chemical 
compounds. Along this line, removal of the myofiber plasmalemma drives quiescent 
satellite cells to activation and proliferation (Bischoff, 1986). Additionally recent 
studies have revealed that numerous factors that regulating satellite cell homeostasis 
are presented on myofibers or secreted by myofibers. For example, IL6 and IL4, two 
cytokines that mediate a paracrine control of SC proliferation and fusion respectively, 
are expressed in and secreted from the myofibers. Their expression is controlled by 
transcription factor SRF in the myofibers (Guerci et al., 2012). Transmembrane Notch 
ligand Delta is reported to be up-regulated in myofibers after muscle injury. Delta 
binds to the Notch receptor in the satellite cells and activates the Notch signaling 
cascade thereby inducing cell proliferation in response to injury (Conboy et al., 2003). 
Therefore the muscle fiber degenerates, which probably leads to niche destruction 
and a loss of inhibitory signals.  
   The basal lamina, consisting of a network of the extracellular matrix (ECM), 
covering the myofibers is another main anatomical hallmark of the satellite cell niche. 
The molecules within ECM include collagen, laminin, entactin, fibronectin, perlecan, 
and decorin glycoproteins along with other proteoglycans. Changes in ECM 
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composition have been indicated to provide instructive cues thereby regulating 
satellite cell homeostasis and muscle regeneration. Lack of collagen VI in Col6a1–/– 
mice reduces satellite cell self-renewal capability and impairs muscle regeneration 
after muscle injury (Urciuolo et al., 2013). Satellite cells express high levels of 
Laminin receptors α7β1 Integrin (Itg) and dystroglycan (Burkin and Kaufman, 1999; 
Cohn et al., 2002), lack of both causes blunted muscle regeneration in response to 
injury (Cohn et al., 2002). Mice deficient for the Laminin-α2 subunit suffer from 
muscular dystrophy with severely impaired regeneration which can be rescued by 
transgenic expression of a functional basement membrane-dystroglycan linkage 
(Bentzinger et al., 2005; Meinen et al., 2007), suggesting that an intact ECM is 
essential for maintenance of satellite cell properties and for muscle repair.  
   The satellite cell niche is composed of different cell types such as Ang1-
expresssing endothelial cells and fibroblasts as well (Abou-Khalil et al., 2009; 
Christov et al., 2007). It is becoming clear that other cell types for example fibro-
adipogenic progenitors (FAPs) and TCF4+ fibroblasts influence satellite cell behavior 
in contexts of regeneration and growth (Joe et al., 2010a; Murphy et al., 2011). 
However it remains to be determined whether such cell types constitute the niche 
and therefore regulate homeostasis or function as paracrine agents involved in 
proliferation and differentiation of satellite cell progeny.  
   Mechanical and structural properties of the niche are also important for satellite cell 
function. It has been observed that satellite cells cannot be removed from niche and 
maintained in vitro without a loss of stem cell characteristics (Cosgrove et al., 2009; 
Wilson and Trumpp, 2006). However, recently Gilbert et al demonstrated that 
isolated satellite cells cultured for short-term on elastic surfaces mimicking the 
softness of adult skeletal muscle better maintain stem cell properties than cells 
growing on rigid surfaces (Gilbert et al., 2010).  
   Taken together these findings suggest that a better understanding of the muscle 
stem cell niche will eventually help us to develop techniques for the ex vivo 
cultivation of satellite cells, allowing genetic correction and stem cell therapy for 
satellite cell related muscle diseases. 
1.3.4 Different genetic requirement of developmental and regenerative 
myogenesis 
Given that regenerative myogenesis relies on muscle stem cells that are derived from 
muscle progenitor cells during developmental myogenesis to build up muscle in adult, 
it has been proposed that the cellular mechanisms controlling adult regenerative 
myogenesis and developmental myogenesis are similar (Parker et al., 2003). Along 
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this line, myogenic factors such as MyoD, Myf5 and Myogenin play similar role in 
developmental and regenerative myogenesis. However recent evidence indicated 
multiple cellular differences between them. Firstly when cultured in vitro, embryonic, 
fetal and adult myoblasts differ in their appearance, media requirements, responding 
to extrinsic signaling molecules, drug sensitivity, and morphology of myofibers 
derived from them. While embryonic myoblasts are elongated cells (Figure 1.3.4.1A) 
and could differentiate into mononucleated or oligonucleated myotubes, fetal 
myoblasts show a triangular shape (Figure 1.3.4.1B), proliferate to limited passages 
in response to growth factors and differentiate into large multinucleated myotubes. 
Satellite cells on the other hand are the only clonogenic cells with round shape 
morphology (Figure 1.3.4.1C), undergo senescence after a limited number of 
passages in vitro and differentiate into large multinucleated myotubes.  
 
 
 
 
   Furthermore it has been shown that differentiation of embryonic myoblasts is 
insensitive to signal molecules such as TGFβ and BMP-4 (Biressi et al., 2007), both 
of which could block differentiation of fetal myoblast and satellite cells. Additionally 
embryonic myoblasts present a different sensitivity to merocynine 540 and phorbol 
esters (TPA) as compared to fetal myoblast and satellite cells (Nameroff and Rhodes, 
1989) (See also in Table 1).  
   Secondly while embryonic and fetal muscle development depends on highly 
proliferative primary and secondary myoblasts without intermittent quiescence, 
satellite cells under non-regenerative physiological conditions are normally quiescent 
in vivo. During regeneration, and in contrast to muscle precursors, some activated 
satellite cells self-renew and return to quiescence to replenish the stem cell pool 
(Figure 1.3.4.2). This process has been attributed to asymmetric cell divisions of 
satellite cells (Braun and Martire, 2007; Kuang et al., 2007). Last but not the least, in 
Figure 1.3.4.1 Different morphology of embryonic, fetal and adult myoblasts. 
Phase contrast images showing that murine embryonic (A), fetal (B) myoblast and satellite 
cells (adult myoblasts) (C) were cultured in 20% fetal calf serum containing medium. Scale 
bar, 50 μm (Biressi et al., 2007).  
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Table 1 Summary of characteristics of embryonic, fetal, and adult myoblasts and 
myofibers (Murphy and Kardon, 2011).  
Figure 1.3.4.2 Regenerative myogenesis versus developmental myogenesis 
(A) The progression of adult muscle satellite cells toward new muscle fiber formation. (B) The 
progression of somitic cells toward myogenesis during development (Buckingham and Rigby, 
2014). 
INTRODUCTION 
 
15 
 
the developing embryo, rapidly dividing muscle precursors apparently do not receive 
signals from their microenvironment that would suffice for them to enter quiescence. 
In contrast, it has been shown that signals emanating from the adult muscle stem cell 
niche play key roles in regulating stem cell asymmetry, fate and behavior 
(Chakkalakal et al., 2012). Further studies aiming to identify distinct cellular and 
molecular characteristics of embryonic myoblasts, fetal myoblasts and satellite cells 
will help to fully understand the distinct genetic requirements for developmental and 
regenerative myogenesis.  
1.4 Satellite cell proliferation and Duchenne muscular 
dystrophy 
The essential role of satellite cells for muscle regeneration in physiological conditions 
is further supported by the fact that deregulation of satellite cell homeostasis is 
causally involved in the pathology of multiply muscle diseases. Among the mostly 
studied examples is the Duchenne muscular dystrophy (DMD). DMD is a lethal X-
linked recessive disease caused by the mutations in the gene encoding the 
cytoskeletal protein dystrophin, which links the inner cytoskeleton to the extracellular 
matrix and therefore plays a key role in plasma membrane integrity in both skeletal 
and cardiac muscles (Petrof et al., 1993). DMD is characterized by severe 
progressive muscle wasting and chronic cycles of muscle degeneration and 
regeneration (Bell and Conen, 1968). The disease also affects the cardiac muscle 
leading to dilative cardiomyopathy (DCM) in 90% of patients. Death usually occurs in 
the second or third decade of life and is due to respiratory or circulatory failure (de 
Kermadec et al., 1994; Eagle et al., 2002). Satellite cells and their progeny, 
myoblasts are thought to gradually lose their proliferative and differentiating capacity, 
and are eventually exhausted in Duchenne muscular dystrophy, due to repeated 
activation, proliferation and limited self-renewal capacity (Blau et al., 1983; Blau et al., 
1985; Heslop et al., 2000). As a result muscle regeneration is impaired in the 
advanced state of the disease and muscle tissues are gradually replaced by adipose 
and fibrotic tissues. Satellite cells isolated from DMD patients exert severe 
proliferation inhibition and DMD is therefore considered to be stem cell dysfunction 
disease as well (Blau et al., 1983). 
   The most widely used animal model for DMD are dystrophin mutant (mdx) mice. 
The first mice strain (C57BL/10-Dmdmdx), which was described in 1984, arose in an 
inbred colony of C57BL/10 mice. Despite sharing the same genetic defect as DMD 
patients (mutations in the dystrophin gene), mdx mice have an almost normal life 
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span and show slowly progressive muscle pathology, with the exception of the 
diaphragm muscle. Mdx mice have no widespread formation of fibrous connective 
tissue and no loss of muscle mass, all of which characterize the human DMD 
(DiMario et al., 1991; Straub et al., 1997). The similar proliferation rate of satellite 
cells from wild type and mdx explains the lack of characteristics of DMD within mdx 
mouse model. Along this line recently Sacco et al. demonstrated that mdx mice 
lacking telomerase activity show shortened telomeres in muscle cells, impaired 
proliferation of satellite cells and a severe dystrophic phenotype similar to human 
DMD (Sacco et al., 2010). Together with a previous report of a 14-fold shortening of 
telomeres in DMD patients relative to healthy individuals (Decary et al., 2000), these 
studies suggest that a difference in the length of telomeres between humans (5-15 
kbs) and mice (>40 kbs) explains the difference in proliferative potential of muscle 
satellite cells between DMD patients and mdx mice. This also indicates targeting 
satellite cell proliferation might provide an alternative therapeutic strategy for human 
DMDs.  
1.5 Protein arginine methyltransferase family (PRMTs) 
Histones undergo a variety of post-translational modifications in their globular 
domains and N-terminal tails, among which lysine acetylation and methylation have 
been extensively studied (Greer and Shi, 2012; Margueron and Reinberg, 2011). 
Besides these modifications, arginine residue can also be modified by a distinct 
group of enzymes termed protein arginine methyltransferases (PRMTs). In 
eukaryotes, PRMTs catalyze the addition of one or two methyl groups to the 
guanidino nitrogen atoms of arginine resulting in either ω-NG-monomethylarginine 
(MMA), ω-NG,NG-asymmetric (aDMA) or ω-NG,N’G-symmetric dimethylarginine 
(sDMA) (Yang and Bedford, 2013). According to their catalytic activities, PRMTs 
could be classified as type I, type II or type III enzymes. Type I and type II enzymes 
catalyze the formation of MMA as an intermediate. Furthermore type I enzymes 
including PRMT1, 2, 3, 4, 6 and 8 catalyze the formation of aDMA whereas type II 
PRMTs including PRMT5, 7 and potentially PRMT9 catalyze the formation of sDMA 
(Figure 1.5.1) (Auclair and Richard, 2013). Certain substrates can only be 
monomethylated by PRMT7 that is referred as type III PRMTs (Miranda et al., 2004).  
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   PRMTs are AdoMet-dependent methyltransferases catalyzing highly specific 
methyl group transfers from the ubiquitous cofactor S-adenosyl-l-methionine (AdoMet) 
to a multitude of biological targets in the cell (Wei et al., 2014). PRMTs vary in length, 
but all contain a conserved core region including a methyltransferase (MTase) 
domain, a β-barrel, and a dimerization arm. While the MTase binding domain is 
highly conserved in AdoMet-dependent methyltransferases, the 7 β-barrel domains 
are quite unique to the PRMT family (Cheng et al., 2005). As shown in Figure 1.5.2, 
PRMTs have 1–2 highly conserved MTase domains, which include motif I 
(VLD/EVGXGXG), post I (V/IXG/AXD/E), motif II (F/I/VDI/L/K), motif III (LR/KXXG), 
and THW loop(Yang and Bedford, 2013). 
   Similar to other post-translational modifications, methylated arginine motifs serve 
as binding sites for specialized protein domains. Currently, the tudor domain is one 
well known domain that binds to methylarginine motifs. the tudor domain can be 
divided into methylarginine and methyllysine binding classes based on high order 
structures but not to their primary sequences. Structural studies have revealed that 
the aromatic cages on methylarginine-binding tudor domains are narrower than the 
methyllysine-binding cages, which favors the planar methyl-guanidinium group (Liu et 
al., 2012; Tripsianes et al., 2011). Methylation of arginine leads to an increase of bulk 
and hydrophobicity of the arginine residue, which facilitates non-electrostatic contacts 
Figure 1.5.1 Protein arginine methylation. 
Arginine residues are methylated by members within protein arginine methyltransferase 
(PRMT) family. PRMTs catalyze either the formation of monomethylarginine (MMA), 
asymmetric dimethylarginine (aDMA) or symmetric dimethylarginine (sDMA). The type I 
enzymes form aDMA and the type II enzymes form sDMA and both catalyze the formation of 
MMA as an intermediate. (Auclair and Richard, 2013) 
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with the aromatic cage of the Tudor domain. In the cage, cation‑π contacts between 
aromatic rings and the cationic carbon of the methylarginine residue stabilize the 
interaction (Liu et al., 2012; Tripsianes et al., 2011). To date there are more than 30 
Tudor domain-containing proteins (TDRDs) identified in mammalian genome (Chen 
et al., 2011). 
 
 
 
 
      Another protein module that has been identified to specifically recognize 
methylation arginine is the plant homeodomain (PHD) finger. PHD finger within 
protein RAG2 binds to H3R2me2s/K4me3 doubly modified peptides slightly better 
than to H3R2me2a/K4me3 and H3K4me3. Further structure analysis revealed that a 
Tyr residue in this domain that is not conserved in other PHDs, provides a preferred 
interacting surface for H3R2me2s (Ramon-Maiques et al., 2007). However, the 
biological signiﬁcance of the interaction of RGA2 PHD fingers with the doubly 
modiﬁed H3 histone tail (H3R2me2s + H3K4me3) is still not clear.  In addition, the 
PHD finger within the ADD domain of the DNA methyltransferase DNMT3A has been 
shown to directly bind to H4R3me2s thereby targeting DNA methylation and silencing 
transcription of the human -globin locus (Zhao et al., 2009). Given the prevalence of 
arginine methylation in the cell, it is most likely that only a small proportion of the 
methylarginine effectors have been identified. New screening approaches aiming to 
identify additional ‘readers’ of these methyl modifications will help to understand the 
signal transduction pathways that emanate from this type of PTM (Yang and Bedford, 
2013).  
Figure 1.5.2 The schematic domain structure of PRMTs. 
All PRMTs universally have 1–2 methyltransferase (MTase) domains (Wei et al., 2014). 
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   Removal of arginine methylation is biochemically difficult. One possibility is to 
convert non- or mono- methylated arginine to citrulline (Figure 1.5.3) (Cuthbert et al., 
2004; Wang et al., 2004), leading to loss of arginine methylation marks. The key 
enzymes catalyzing arginine to citrulline belong to a family of proteins called 
peptidylarginine deiminase (PADIs). PADI4 has been recently shown to convert R2 
and R17 at histone H3 tails to citrulline, counteracting arginine methylation catalyzed 
by PRMT6 and PRMT4, respectively (Cuthbert et al., 2004; Kolodziej et al., 2014). 
 
 
   Additionally it has been shown that Jumonji C domain containing protein JMJD6 is 
capable of directly erasing mono- and di-methyl arginine marks without altering the 
protein sequence (Chang et al., 2007) . However, this finding has recently been 
questioned (Webby et al., 2009). Thus it is still unclear whether there is enzymatic 
reaction that directly removes methyl groups from arginine in histones or other 
proteins.  
1.6 Protein arginine methyltransferase 5 (PRMT5) and 
symmetric arginine methylation 
PRMT5 is the major symmetric arginine dimethyltransferases and has been shown to 
play a pivotal role in regulating multiple cellular processes ranging from transcription 
repression, RNA processing to cell signaling, differentiation, apoptosis and 
Figure 1.5.3 An outline of the protein citrullination (deimination) process.  
Calcium-dependent peptidylarginine deiminases (PADIs) convert peptidylarginine into 
peptidylcitrulline resulting in altered protein function (Jang et al., 2013). 
 
INTRODUCTION 
 
20 
 
tumorigenesis (Bedford and Clarke, 2009). Consistently complete loss of this enzyme 
is not compatible with mouse or cell viability (Tee et al., 2010). PRMT5 exists both in 
nucleus and in cytoplasm with distinct substrate and functions. In the nucleus, 
PRMT5 has been shown to symmetrically dimethylate histones H2AR3, H3R8, H4R3 
and many transcription factors (Karkhanis et al., 2011). Association of PRMT5 with 
various binding partners appears to influence its substrate specificity. For instance a 
nuclear protein called cooperator of PRMT5 (COPR5) was identified as a PRMT5 
interacting partner by the yeast two-hybrid assay and might recruit PRMT5 
preferentially to methylate histone H4R3 in vitro (Lacroix et al., 2008).  
1.6.1 Symmetric arginine methylation and transcription repression 
Using ChIP and ChIP-seq methods, it has been shown that H4R3me2s is strongly 
correlated with repression of transcription (Barski et al., 2007; Wang et al., 2008; Xu 
et al., 2010). Furthermore H4R3me2s has also been shown to be mono-allelic within 
the H19 imprinting control region (Jelinic et al., 2006), suggesting that symmetric 
arginine methylation might regulate imprinting gene silencing. Mechanistically 
H4R3me2s serves as a direct binding target for the DNA methyltransferase DNMT3A, 
which interacts through the ADD domain with a PHD motif. During the silencing of the 
human beta-globin gene and C/EBPβ target genes, H4R3me2s is required for 
DNMT3A binding and DNA methylation in the promoter regions of those genes 
(Tsutsui et al., 2013). However this finding has not been supported by subsequent 
structure analysis of the DNMT3A ADD domain (Otani et al., 2009) or by peptide 
array screening for interaction partners using the same domain (Zhang et al., 2010), 
suggesting a more complicated situation of H4R3me2s in mediating DNMT3A 
binding, DNA methylation and gene silencing. In support of this H4R3me2s has also 
been shown to act independently from repressive epigenetic modifications such as 
H3K9me3, H4K20me3 and DNA methylation at imprinted gene loci (Girardot et al., 
2014). While many findings support an positive correlation of symmetric arginine 
methylation and gene silencing, a recent ChIP-seq study using another specific 
antibody show that H4R3me2s is a hallmark of G+C-rich sequence elements, but is 
generally independent of the transcriptional status or methylated DNA in ES and 
MEF cells (Girardot et al., 2014), suggesting more complicated transcriptional 
regulation by symmetric arginine methylation.  
1.6.2 Transcription repression by PRMT5 
Recent studies indicate that PRMT5 suppresses gene expression by either modifying 
histones in concert with a variety of other epigenetic modifiers including ATP-
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dependent chromatin remodelers and co-repressors or indirectly modulating the 
activity of specific transcription factors (Dacwag et al., 2007; Hosohata et al., 2003; 
Pal et al., 2004). Furthermore, PRMT5 has been shown to induce additional 
repressive epigenetic marks at the fetal globin gene promoter in an erythroid cell line 
through the assembly of a multi-protein repressor complex containing the histone 
modifying enzymes Suv4-20h1 and casein kinase 2alpha (CK2alpha), which catalyze 
tri-methylation of H4K20 and phosphorylation of H4S1, respectively (Rank et al., 
2010). Unlike the genome wide studies by ChIP-seq, it has been shown that PRMT5 
mediated H4R3me2s recruit Polycomb proteins in a Groucho related protein (Grg) 
dependent manner leading to tri-methylation of H3K27 and subsequently gene 
silencing (Tae et al., 2011). 
   PRMT5 induced transcription repression has also been shown in execution with 
ATP-dependent chromatin remodelers. Affinity purification and ChIP assay showed 
that PRMT5 and its binding partner MEP50 form complex within NuRD (Nucleosome 
Remodeling and Deacetylation complex) (Le Guezennec et al., 2006). PRMT5-NuRD 
complex co-occupies promoters of target genes including CDKN2A (which encodes 
p14ARF and p16INK4a). Furthermore, enrichment of PRMT5-NuRD at the promoter 
of target genes depends on DNA methylation given that treatment with the DNMTs 
inhibitor 5-aza-2'-deoxycytidine (5-azadC) reduces their association with target 
promoters (Le Guezennec et al., 2006). Mechanistically PRMT5 reduces the 
interaction between MBD2 and histone deacetylase within NuRD complex by directly 
methylating MBD2 thereby lowering the association of NuRD complex with 
methylated promoter DNA and gene repression (Tan and Nakielny, 2006). PRMT5 
forms a complex with other ATP-dependent chromatin remodelers: BRG1- or hBRM-
based hSWI/SNF complexes, which is capable of mediating target gene repression 
by efficiently histone H3 and H4 symmetric arginine methylation (Pal et al., 2004). 
Notably SWI/SNF-PRMT5 complex induced transcriptional silencing is context 
dependent as well. For instance at the early stage of skeletal muscle differentiation, 
PRMT5 is required for myogenin expression by direct binding to the promoter and 
facilitate SWI/SNF complexes interaction and remodeling at myogenin locus 
(Dacwag et al., 2009). In multiple cell culture models for adipogenesis, the presence 
of PRMT5 and H3R8me2s promotes the binding of SWI/SNF complexes, which is 
required for the binding of PPARγ2 at PPARγ2-regulated promoters and activation of 
adipogenic genes (LeBlanc et al., 2012). However the transition between activation 
and repression of PRMT5 function is still unknown. 
   In addition, PRMT5 has been shown to be involved in RNA mediated gene 
silencing by methylating the small RNA-binding protein Piwi, which is exclusively 
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present in germ cells and interacts with a specific class of small non-coding RNAs 
called piwi-interacting RNAs (piRNAs). In mouse embryonic germ cells, members of 
the Piwi family repress transcription of transposable elements by inducing de 
novo methylation of their DNA sequences. Biochemical purification of Piwi interacting 
proteins led to the identification of several Tudor domain-containing proteins 
including PRMT5.  Mutation of specific arginine residues within the N-terminal region 
of one Piwi protein MILI results in loss of interaction and co-localization with Tudor 
proteins, suggesting that PRMT5-induced methylation of Piwi proteins is critical for 
their recognition by the Tudor family of proteins and proper function of the piRNA 
pathway (Vagin et al., 2009). 
1.6.3 PRMT5 methylates transcription factors 
Emerging evidence has shown that PRMT5 methylates not only histones but also a 
host of transcriptional factors including E2F-1, p53, SPT5, p65 and homeobox A9 
(HOXA9) in nucleus (Bandyopadhyay et al., 2012; Cho et al., 2012; Jansson et al., 
2008; Kwak et al., 2003; Wei et al., 2013). PRMT5 directly methylates E2F-1 in tumor 
cell lines, through which stabilizes E2F1 protein, increases E2F1 DNA binding activity 
hence up-regulates E2F1 target gene transcription coordinating with decreased cell 
growth rate and apoptosis (Cho et al., 2012). PRMT5 has also been shown to 
interact with and methylate tumor suppressor p53, at R333, R335 and R337 upon 
DNA damage. Methylation of p53 by PRMT5 leads to inhibition of p53 
oligomerization, impairment of recruitment to target genes and suppression of gene 
expression upon DNA damage (Jansson et al., 2008). Moreover, PRMT5 directly 
interferes gene expression by methylating the transcription elongation factor SPT5, 
leading to decreased interaction between SPT5 and elongating RNA polymerase II 
thereby silencing IκBα and IL-8 gene expression (Kwak et al., 2003). PRMT5 is the 
only arginine methyltransferase that methylates p65, a subunit of NF-κB, resulting in 
the enhanced binding of NF-κB to κB elements and gene repression (Wei et al., 
2013). The homeobox transcription factor HOXA9 is essential for the induction of 
proinflammatory proteins in endothelial cells (EC) in response to stimuli and PRMT5 
was shown to activate HOXA9 by dimethylating Arg140 within this protein 
(Bandyopadhyay et al., 2012) 
1.6.4 PRMT5 methylates multiple targets in cytoplasm 
PRMT5 mediated arginine methylation has been implicated in a variety of cytosolic 
processes as well, including biogenesis of Sm-class ribonucleoproteins, assembly of 
the Golgi apparatus and ribosome biogenesis. Sm proteins are components of the 
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spliceosomal U1, U2, U4 and U5 small nuclear ribonucleoproteins (snRNPs). In the 
cytoplasm, PRMT5 acts together with pICln and WDR77 as part of the methylosome, 
which mainly methylates Sm proteins (SmB/B’, SmD1, and SmD3), increasing their 
affinity for the Tudor domain of spinal motor neuron 1 (SMN1) (Friesen et al., 2001; 
Meister and Fischer, 2002), facilitating their loading onto the Sm site of small nuclear 
RNA (snRNA) thereby giving rise to U-snRNPs. The absence of PRMT5 results in 
reduced methylation of Sm proteins and aberrant constitutive splicingThe aberrant 
splicing of specific mRNAs in neural stem cells of PRMT5 mutant (Bezzi et al., 2013) 
provides confirmation for the role of PRMT5 in RNA processing.  
   PRMT5 has been shown to form a complex with GM130, a Golgi matrix protein, 
and co-localizes with other Golgi markers in Golgi apparatus (Zhou et al., 2010) 
PRMT5 methylates GM130 at R6, R18 and R23, affecting ribbon formation of Golgi 
apparatus. Consistently knockdown of PRMT5 reduces GM130 methylation and 
increases fragmented Golgi apparatus (Zhou et al., 2010). PRMT5 has been shown 
to interact with and methylate ribosomal protein S10 (RPS10), a member of the 
ribosome 40S subunit (Gary and Clarke, 1998). Methylation of RPS10 appears to be 
critical for ribosome assembly, protein synthesis and cell proliferation. Mutations that 
affect methylated arginine residues result in an unstable protein that is inefficiently 
incorporated into ribosomes. Moreover, RPS10 knockdown cells grow slower than 
control cells, and re-expression of wild type, but not mutant RPS10 restores cell 
proliferation, highlighting the importance of PRMT5-induced methylation in ribosome 
biogenesis and growth control (Gary and Clarke, 1998). 
   Interestingly recent studies revealed that cellular localization of PRMT5 appears to 
be dependent on whether cells are non-transformed or transformed. While in most 
primary and immortalized cells, PRMT5 is primarily located in the cytosol with a small 
amount in the nucleus, in transformed cells PRMT5 is mainly enriched in nucleus 
(Pal et al., 2007). This suggests distinct function of PRMT5 in the control of cell 
growth and proliferation. For instance, cytoplasmic PRMT5 is capable of directly 
interacting with and monomethylating R1175 at epidermal growth factor receptor 
(EGFR), a transmembrane receptor whose activation in turn initiates downstream 
signaling events associating with cellular proliferation and tumorigenesis, in non-
transformed cells (Hsu et al., 2011). Methylation of EGFR suppresses EGFR function 
by promoting phosphorylation of Tyr1173 and subsequently inhibits ERK signaling, 
suggesting a crosstalk between arginine methylation and tyrosine phosphorylation in 
regulating cell proliferation. Relocation of PRMT5 from the cytosol to the nucleus in 
transformed cells results in reduced EGFR methylation thereby potentiating ERK 
signaling and enhancing cell proliferation of cancer cells (Hsu et al., 2011). Notably 
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recent proteomic analysis of symmetric methylated protein revealed that many 
arginine sites in distinct proteins are modified indicating that PRMT5 is involved in a 
network regulating distinct cellular processes (Chang et al., 2013). A systematic 
analysis ofthe role of PRMT5 in the network will further improve our understanding of 
symmetric arginine methylation and biology of cancer and stem cell. 
1.6.5 PRMT5 function in stem cells  
The critical role for PRMT5 during embryonic development has been recently 
demonstrated by a study showing that Prmt5-null mice are early embryonic lethal 
between E3.5 to E6.5 (Tee et al., 2010). In addition, the failure to derive embryonic 
stem (ES) cells from Prmt5-null blastocysts together with down-regulation of 
pluripotency genes and up-regulation of differentiation genes in PRMT5 knockdown 
ES cells strongly indicated that PRMT5 is required for stem cell pluripotency. 
Furthermore PRMT5 promotes somatic cell reprogramming to the induced pluripotent 
stem (iPS) cells with classical Yamanaka factor protocol (OCT3/4, SOX2, KLF4, 
MYC)  (Nagamatsu et al., 2011; Takahashi and Yamanaka, 2006). Mechanistically 
cytoplasmic PRMT5 forms a complex with signal transducer and activator of 
transcription (STAT3) and represses differentiated differentiation gene in ES cells 
thorugh the leukemia inhibitory factor (LIF) -STAT3 signaling pathway (Tee et al., 
2010). PRMT5 not only plays an essential role in embryonic stem cells but also 
regulate proliferation of adult stem/progenitor cells during development. Recently, it 
has been demonstrated that PRMT5 controls neural stem/progenitor cells (NPCs) 
homeostasis (Bezzi et al., 2013). The conditional ablation of PRMT5 in the Nestin+ 
NPCs leads to the cell cycle block, triggers cell death and finally results in the 
postnatal death in mice. At the molecular level, the absence of PRMT5 results in 
reduced methylation of Sm proteins, aberrant constitutive splicing, and the alternative 
splicing of specific mRNAs with weak 5′donor sites. Intriguingly, Mdm4 is identified 
as one of these key mRNAs that senses the defects in the spliceosomal machinery 
and transduces the signal to activate the p53 response. Consistently, ablation of p53 
in NPCs rescues neural stem cell proliferation, providing a mechanistic explanation of 
the phenotype observed in vivo (Bezzi et al., 2013). Given that the proliferation of 
adult stem cells is following after activation in response to specific signals in their 
microenvironment, and is always accompanied with self-renewal that governs the 
stem cells re-entry into quiescence, suggesting that PRMT5 might regulate adult 
stem cell homeostasis differently.  
  PRMT5 has also been implicated in epigenetic regulation during mouse germ cell 
specification by directly interacting with the transcriptional repressor B-lymphocyte-
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induced maturation protein (BLIMP1) (Ancelin et al., 2006). Translocation of the 
BLIMP1–PRMT5 complex from the nucleus to the cytoplasm during embryogenesis 
results in reduced methylation in H2AR3/H4R3 and de-repression of genes involved 
in germ cell specification. Moreover, BLIMP1 over-expression in embryonic P19 
carcinoma cells results in repression of germ cell specification genes and increased 
methylation of histones H2AR3 and H4R3 (Ancelin et al., 2006; Eckert et al., 2008). 
The crucial role of PRMT5 in germ cell formation is further demonstrated by recent 
genetic studies in Drosophila. Loss of dart5 (also called Capsuleen), the fly ortholog 
of PRMT5, causes defects in spermatocyte maturation and infertility. While female 
dart5 mutants are fertile, their embryos fail to form the pole cells that give rise to 
germ cells in adults (Gonsalvez et al., 2006), supporting the important role of PRMT5 
in germ cell formation. At the molecular level, Dart5 is required for the methylation of 
spliceosomal proteins in oocytes thereby controlling the localization of these proteins 
in the pole plasma, loss of which leads to impaired germ cell formation (Anne et al., 
2007).  
1.6.7 PRMT5 acts as an oncogene in cancer 
Emerging evidence has shown that PRMT5 plays an important role in tumorigenesis 
and might be a potential therapeutic target for cancer treatment. Overexpression of 
PRMT5 has been shown in many patient-derived primary cancers such as liver, 
pancreas, skin, breast, cervix, prostate, kidney, ovary, bladder and lung, with 
strikingly elevated expression in colon cancer. Expression of PRMT5 is thus 
positively correlated with growth rate of cancer cells and inversely correlated with 
overall patient survival (Wei et al., 2013). Distinct mechanisms by which PRMT5 
controls tumorigenesis have been revealed. PRMT5 might function as oncogene-like 
protein due to its ability to repress the expression of tumor suppressor genes,  to 
control cell cycle progression, to alter epigenetic modifications of cancer cells and to 
deregulate oncogenic signaling pathways. Pal et al showed that in mouse embryonic 
fibroblast cell lines, PRMT5 acts as an oncogene by decreasing the expression of 
tumor suppressor genes like the suppressor of tumorigenicity 7 (ST7) and 
nonmetastatic 23 (NM23) (Pal et al., 2004). Along this line increased levels of 
PRMT5 and transcriptional silencing of ST7 are associated with more aggressive 
disease in patients with glioblastoma (Yan et al., 2014). Chung et al. showed that 
inhibition of PRMT5 in non-Hodgkin lymphoma cell lines reactivates the 
Retinoblastoma (Rb) tumor suppressor pathway and Polycomb Repressor Complex 
2 (PRC2) silencing thereby inducing lymphoma cell death (Chung et al., 2013). In an 
orthotopic model of breast cancer, Powers et al showed that PRMT5 methylates 
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tumor suppressor programmed cell death 4 (PDCD4) at R110 thereby involving in 
breast cancer control (Powers et al., 2011). In human osteogenic sarcoma SAOS2 
cells, PRMT5 ablation induces the expression of p53 resulting in p53-dependent 
apoptosis and cell cycle arrest in the G1 phase (Jansson et al., 2008). PRMT5 has 
also been shown to up-regulate cyclin-dependent kinases (CDKs) and the PI3K/AKT 
signaling cascade, both of which are the key players in cancer (Wei et al., 2012). In 
human patients with myeloproliferative neoplasms, the strong interaction between 
PRMT5 and constitutively activated form of JAK2 (JAK2-V617F) inhibits its 
methyltransferase activity and promotes myeloproliferation (Liu et al., 2011). In 
multiple endocrine neoplasia type 1 (MEN1) tumor PRMT5 interacts with menin and 
suppresses the Hedgehog signaling by dimethylating histone H4R3, which also 
strengthen the role ofPRMT5 as a therapeutic target in treating this tumor (Gurung et 
al., 2013). Moreover, PRMT5 has also been demonstrated to be an essential 
component of the hypoxia-inducible factor 1 (HIF-1) signaling pathway involved in 
attenuating the hypoxic induction of HIF-1α in human lung adenocarcinoma, 
fibrosarcoma, and mammary carcinoma cell lines (Lim et al., 2012) and of nuclear 
factor κB (NF-κB) pathway by dimethylating R30 of the p65 subunit in diverse human 
cancers (Wei et al., 2013).  
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2. OBJECTIVES 
Multiply tissue specific adult stem cells originate from highly proliferative progenitor 
cells during development. For instance, skeletal muscle contains a rare, specialized 
subset of myofiber-associated adult stem cells called satellite cells, which are derived 
from a population of proliferative Pax7+/MyoD+ muscle precursors during early 
embryonic development. In resting muscle these cells are in quiescent state. Upon 
muscle injury or excessive exercise, satellite cells exit quiescence, activate, 
proliferate and differentiate eventually generating new myofibers. Understanding the 
molecular mechanisms underlying satellite cell homeostasis in adult and muscle 
progenitor proliferation during development is therefore essential for muscle 
development and regenerative medicine. Previous studies have shown that 
quiescent satellite cells maintain high content of compacted heterochromatin 
structure that distinguishes them from their precursors and progeny (differentiated 
myocytes). This indicates that distinct epigenetic determinants regulating satellite cell 
homeostasis during regenerative myogenesis from muscle precursors during 
developmental myogenesis. To identify and elucidate the epigenetic signatures that 
could distinguish the molecular requirements between these two biological processes, 
I have addressed following objectives: 
(1) Identifying novel epigenetic modifications and modifiers that are specifically 
enriched in satellite cells 
(2) Investigating if the epigenetic modification and modifiers are required for 
maintaining satellite cell homeostasis and muscle regeneration in both 
physiological and pathological conditions.  
(3) Identifying molecular targets mediating for the effects of epigenetic modifies in 
control of satellite cell homeostasis.  
(4) Addressing the potential role of novel epigenetic modifiers in myopathies and 
muscle diseases. 
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3 MATERIALS  
3.1 Chemicals and Enzymes 
Table 3.1: Specific reagents 
Reagent  Manufacturer 
Cardiotoxin ( # C-9759) Sigma-Aldrich Chemie GmbH, Steinheim 
Collagen type 1 (# 354236) BD Biosciences Pharmingen, San Diego, 
USA 
Collagenase type 2 (# 4176) Worthington Biochemical Corporation, 
Lakewood, United States 
Collagenase P (# 11213857001) Roche Diagnostics GmbH, Mannheim, 
Germany 
cOmplete Protease Inhibitor 
Cocktail Tablets 
Roche Diagnostics GmbH, Mannheim, 
Germany 
Dispase (# 354235) BD Biosciences Pharmingen, San Diego, 
USA 
DMSO Sigma-Aldrich Chemie GmbH, Steinheim 
DNase I (# 11284932001) Roche Diagnostics GmbH, Germany 
Dithiothreitol (DTT) AppliChem GmbH, Darmstadt 
Ethidium bromide Sigma-Aldrich Chemie GmbH, Steinheim 
Eosin Y solution, aqueous Sigma-Aldrich Chemie GmbH, Steinheim 
Hematoxylin Gill Sigma-Aldrich Chemie GmbH, Steinheim 
Skimmed milk powder Roth GmbH, Karlsruhe, Germany 
Paraformaldehyde (PFA) Fluka Chemie GmbH, Buchs 
Percoll (# P4937) Sigma-Aldrich Chemie GmbH, Steinheim 
Ponceau S Fluka Chemie GmbH, Buchs 
Protein Standard (Novex ® Sharp 
Protein Standard) 
Invitrogen GmbH, Karlsruhe 
 
Rnase,Dnase-free(#11119915001) Roche Diagnostics GmbH, Mannheim, 
Germany 
Tissue-Tek ® O.C.T. PolyfreezeTM 
freezing 
Miles Inc., Diagnostic Division, Elkhart, 
United States 
TRIZOL ® reagent Invitrogen GmbH, Karlsruhe 
Matrigel BD Biosciences, Greiner 
Mowiol 4-88 Fluka Chemie GmbH, Buchs 
Protein A Agarose Roche Diagnostics GmbH, Germany 
Protein G Agarose Roche Diagnostics GmbH, Germany 
Chelex®100 Resin BioRad Laboratories GmbH, Munchen 
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3.2 Ready-reaction systems 
Table 3.2: Used Kits 
Kit Manufacture 
Click-iT EdU Invitrogen GmbH, Karlsruhe 
In Situ Cell Death Detection Kit, TMR red 
 
Roche Diagnostics GmbH,  Germany 
DC ™ protein kit BioRad Laboratories GmbH, Munchen 
Masson's trichrome Sigma-Aldrich Chemie GmbH, 
Steinheim 
Absolute ™ SYBR ® Green Fluorescein 
Mix 
 
Thermo Fisher Scientific, Rockford, 
USA 
 
MinElute PCR Purification Kit QIAGEN GmbH, Germany 
Qubit® dsDNA HS Assay Kit Invitrogen GmbH, Karlsruhe 
 
3.3 Buffers and Solutions 
All buffers and solutions were prepared with water that previously available via a 
Treatment system (MilliQ Plus Water System, Millipore GmbH, Schwalbach/Ts) to 
the quality grade "double-distilled”. 
 
Table 3.3.1: Standard buffers  
Standard buffers Composition 
PBS 137 mM NaCl, 2.7 mM KCl, 10 mM Na2HPO4, 2 mM 
KH2PO4 
PBST PBS containing 0.1% Tween 20 
SDS running buffer (10x) 250 mM Tris base, 1% SDS, 1.9 M Glycine 
 
Semi-dry transfer buffer 25 mM Tris base, 192 mM Glycine, 20% Methanol 
 
Whole cell extraction 
buffer 
100mM Tris-HCl, pH 7.9, 1M MgCl2, 1M KCl, 0.1M 
EDTA, protease inhibitor cocktail 
Red blood cell lysis buffer  
 
1.5M NH4Cl, 100 mM KHCO3, 10 mM EDTA,add 5 
μg/ml Dnase I before use 
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Table 3.3.2: buffers for ChIP and ChIP-seq 
ChIP buffers Composition 
Cell lysis buffer 5mM HEPES pH8, 85mM KCl, 0.5% NP-40, Protease 
inhibitors 
Nuclear lysis buffer  50 mM Tris-HCl, pH 8.0, 10 mM EDTA, 1% SDS, 
protease inhibitors  
ChIP dilution buffer  20 mM Tris-HCl, pH 8.0, 150 mM NaCl, 2 mM EDTA, 
1% Triton X-100, complete protease inhibitor cocktail 
High salt washing buffer  20 mM Tris-HCl, pH 8.0, 500 mM NaCl, 2 mM EDTA, 
1% Triton X-100 
LiCl washing buffer  10 mM Tris-HCl, pH 8.0, 250 mM LiCl, 1% Na-
deoxycholate, 1% NP40 
TE washing buffer 10 mM Tris-HCl pH 8.0, 1 mM EDTA 
IP elution buffer 100mM NaHCO3, 1%SDS, freshly prepared 
 
3.4 Culture media 
Table 3.4: Culture media 
Mediums Composition 
Growth medium for C2C12 DMEM (Dulbecco's Modified Eagle Medium) with 4.5 
g / l glucose 10% fetal calf serum, 100 U / ml 
penicillin / streptomycin, 20 mM glutamine 
Growth medium for FACS 
isolated satellite cells and 
Freshly isolated myofibers 
 
GlutaMAX ™ DMEM with 4.5 g / l glucose 
20% fetal calf serum, 100 U / ml penicillin / 
streptomycin 15 μg/μl Fibroblast growth supplement 
(FGS) 
 
Differentiation medium DMEM with 4.5 g / l glucose, 2% horse serum, 100 U 
/ ml penicillin / streptomycin, 20 mM glutamine 
 
3.5 Oligonucleotides 
The oligonucleotides used in this work were from Sigma-Aldrich Chemie GmbH, 
Steinheim based. 
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Table 3.5.1: List of primers for genotyping. 
Genotyping Primers Sequence(5'-->3') 
Pax7 CreERT2 Forward ACTAGGCTCCACTCTGTCCTTC 
 Reverse GCAGATGTAGGGACATTCCAGTG 
ZsGreen Forward CTGCATGTACCACGAGTCCA 
 Reverse GTCAGCTGCCACTTCTGGTT 
Rosa26-YFP RosaFA AAA GTC GCT CTG AGT TGT TAT 
 RosaRF GGA GCG GGA GAA ATG GAT ATG 
 Rosa-SpliAC CAT CAA GGA AAC CCT GGA CTA CTG 
mdx mdx_Forward GCGCGAAACTCATCAAATATGCGTGTTAGT
GT 
 mdx WT Reverse GATACGCTGCTTTAATGCCTTTAGTCACTCA
GATAGTTGAAGCCATTTTG 
 mdx MT Reverse CGGCCTGTCACTCAGATAGTTGAAGCCATT
TTA 
p21 p21 exon 144 GAACTTTGACTTCGTCACGG 
 p21 genoU ACAACACCTCCTGGTCAGAGG 
 p21 PGK neo3 GAAGAACGAGATCAGCAG 
Pax7Cre ck188 GCTCTGGATACACCTGAGTCT 
 ck256 TCGGCCTTCTTCTAGGTTCTGCTC 
 ba97 GATCTGGACGAAGAGCATCA 
 ck172 GGATAGTGAAACAGGGGCAA 
Prmt5  P1 TGTAAATATTAAAGGCGCATAAC 
 P2 CTATGGATCTACTTAGGGGCTTC 
 P3 CCAGAACTTCCTCTGGTTTCTGG 
 P4 GAAAGCTGTGTGTGCTCACAC 
HSACreERT2 Forward GAGCCGAGAGTAGCAGTTGT 
 Reverse GGCAAACGGACAGAAGCATT 
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Table 3.5.2: List of primers for RT-qPCR and ChIP-qPCR. 
Name Primer sequence (5'-->3') Annealing 
temperatur
e (°C) 
Application 
Prmt5 Exon5-7 AGAATGCCCCGACTACACAC 56 RT-qPCR 
 AGCCTCTGCTGCACCTTAGA  RT-qPCR 
p21 CGGTGTCAGAGTCTAGGGGA 56 RT-qPCR 
 ATTGGAGTCAGGCGCAGATC  RT-qPCR 
Pax7 GCTACCAGTACAGCCAGTATG 56 RT-qPCR 
 GTCACTAAGCATGGGTAGATG  RT-qPCR 
MyoD GAATGGCTACGACACCGCCTAC
TAC 
60 RT-qPCR 
 CCTACGGTGGTGCGCCCTCTGC  RT-qPCR 
 TGGGCTGGGTGTTAGTCTTA  RT-qPCR 
Myf5 CCACCTCCAACTGCTCTGAC 56 RT-qPCR 
 GCTTCAGGGCTTCTTTTCCT  RT-qPCR 
m36B4 AAGCGCGTCCTGGCATTGTCT 56 RT-qPCR 
   RT-qPCR 
cyclinB1 GGGTGTGCTTTGAATTCTGACA 56 RT-qPCR 
 AGGAGTGGCGCCTTGGTAT  RT-qPCR 
p53 TGCTGTGCAATTAAAGGCTGT 56 RT-qPCR 
 CGTGTTCTCCGAGATACTTGGT  RT-qPCR 
p21 Enhancer CACAGGGAAGAGAGCTCCAG 56 ChIP 
 AGCCAGGGCTACACAGAGAA  ChIP 
p21 TSS TCCACAGCGATATCCAGACA 56 ChIP 
 GGACACACCTGTGACTCTGG  ChIP 
p21 p53 BS CAAGCCCTTCCCAGACTTCC 60 ChIP 
 TCTAGAGATCGCTGCCCAGA  ChIP 
p21 +700bp CCTGTTTCGCGGTAGCCA 60 ChIP 
 ACAATGAGTCACCTCCTCGC  ChIP 
p53 promoter TGCTGTGCAATTAAAGGCTGT 60 ChIP 
 CGTGTTCTCCGAGATACTTGGT  ChIP 
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3.7 Plasmids 
Table 3.7: Plasmids used 
Name Description  Source 
psPAX2 Plasmid for expression of the packaging genes 
gag, pol, and rev for the production of lentiviruses. 
 
Sigma-Aldrich 
GmbH, Steinheim 
pMD2.G A plasmid for expression of the viral Hüllpr oteine 
VSV-G for the preparation of lentiviruses. 
 
Sigma-Aldrich 
GmbH, Steinheim 
 
3.8 Antibodies 
Table 3.8: List of antibodies used in this study, related to the experimental 
procedures 
Antibody Antigen Application  Manufacturer 
Anti‐Pax7 mouse  Pax7 IF  DSHB 
Anti‐CD34 Rat CD34 IF  eBioscience 
Anti‐MyoD rabbit MyoD IF  Santa Cruz 
Anti-MyoD mouse MyoD IF   
Anti-Myogenin rabbit Myogenin IF  Santa Cruz 
Anti-Myogenin mouse Myogenin IF DSHB 
MF20 Myosin heavy chain IF  DSHB 
Anti-Gapdh Gapdh WB Cell signaling 
Anti-PRMT5 PRMT5 WB,ChIP Active Motif 
Anti-p53 p53 WB,ChIP Cell signaling 
Anti-H3R8me2s H3R8me2s WB,ChIP Novus 
Anti-H4R3me2s H4R3me2s WB,ChIP Abcam 
Anti-Histone H3 Histone H3 WB,ChIP Abcam 
Rabbit IgG  ChIP Diagenode 
Mouse IgG  ChIP Diagenode 
Anti‐CD11b PE‐Cy7 CD11b   FACS eBioscience 
Anti‐CD45 PE  CD45 FACS eBioscience 
Anti‐CD31 PE  PECAM1 FACS eBioscience 
Anti‐CXCR4 APC  CXCR4 FACS eBioscience 
Anti‐CD34 A450  CD34 FACS eBioscience 
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3.9 Cell lines 
C2C12   
ATCC CRL-1772 ™ 
A mouse myoblast cell line. These cells are capable of 
differentiation at a low serum concentration in culture. C2C12 
cells were used to study the differentiation of myoblast in vitro 
(Yaffe and Saxel, 1977) 
HEK293T  
ATCC CRL-11268 ™ 
A specific cell line originally derived from human embryonic 
kidney cells. These cells constitutively express the simian 
virus 40 (SV40) large T antigen. 293T cells are suitable for the 
production of virus particles (DuBridge et al., 1987). 
 
3.10 Mouse lines 
Pax7Cre A targeting vector was constructed that placed an ires-Cre-
FRT-Neo-FRT cassette in the ClaI site within the 3’-
untranslated region of the Pax7 gene following the stop 
codon in exon 10. This targeting vector was electroporated 
into R1 ES cells that were then subjected to positive and 
negative selection. Mice that are heterozygous for the 
targeted mutation are viable, fertile, normal in size and do not 
display any gross physical or behavioral (Keller et al., 2004). 
 
Pax7Cre/ERT2 A targeting vector was used to insert loxP sites flanking exon 
2. Exon 2 was excised via transient Cre mediated 
recombination to generate the Pax7tm1.1Fan allele. Exon 1 
in the Pax7tm1.1Fan allele was replaced with a targeting 
vector containing sequence encoding Cre-ERT2, IRES-
DsRed and an FRT flanked PGK-neo cassette. Mice that are 
heterozygous for the targeted mutation are viable, fertile, 
normal in size and do not display any gross physical or 
behavioral abnormalities (Chen-Ming Fan, Carnegie 
Institution of Washington) (Lepper et al., 2009). 
 
Prmt5flox/flox The Prmt5flox/flox mice in the Prmt5 gene locus encoding the 
Exon 7 flanked by two loxP sequences. When crossed with 
the strain expresses Cre recombinase from the targeted 
locus, Cre-mediated recombination results in tissue-specific 
deletion of the Prmt5 sequence. (EUCOMM). 
 
Pax7:ZsGreen A murine BAC containing the Pax7 locus was modified by 
replacing the Pax7 coding sequence from exon 1 with a 
sequence encoding ZsGreen, and transgenic mice were 
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generated by pronuclear injection. These mice allow direct 
access to the satellite cell pool by flow cytometry, enabling 
the direct isolation of a homogeneous cell population for in 
vitro study (Bosnakovski et al., 2008).  
ROSA26-EYFP A generic ROSA26 targeting vector was constructed. Then 
the reporter mice generated was by inserting EYFP or ECFP 
cDNAs into the ROSA26 locus, preceded by a loxP-flanked 
stop sequence. he resulting EYFP or ECFP expression 
patterns indicated that the reporter strains function as faithful 
monitors of Cre activity. (Srinivas et al., 2001) 
 
p21 null mice A targeting vector was constructed containing a 8kb cdkn1a 
genomic sequence with a PGK-neo cassette, that eliminate a 
3kb genomic fragment containing exon 2 of cdkn1a. Its 
replacement through homologous recombination created a 
null mutation (Deng et al., 1995). 
 
mdx mice Duchenne muscular dystrophy (DMD), the Dmdmdx mutants 
do not express dystrophin and therefore have been routinely 
used as an animal model of the disease even though the 
resultant myopathology is much less severe compared to the 
human disease course.(Jackson’s Lab) 
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4 METHODS 
4.1 Isolation of satellite cells and myofibers from adult keletal 
muscles 
4.1.1 Satellite cell isolation and purification by FAC sorting 
Satellite cell isolation and purification were performed according to established 
methods (Gunther et al., 2013). First, limb and trunk muscles were minced, digested 
with 100 caseinolytic units Dispase (BD) in 20ml DMEM supplemented with 
penicillin/streptomycin (DMEMps) in a 50ml Falcon tube at 37°C for 30 minutes, and 
then 20ug type II collagenase (Worthington Biochemicals) was added to the tube to 
make the final concentration as 0.1%. The tube was vortexed to mix the muscle and 
incubated in 37°C for additional 30 minutes. Afterward the digested muscle was 
passed through a 25ml syringe for several times to release the satellite cells from the 
myotubes, and then was filtered through 100 mm, 70 mm, and 40 mm cell strainers 
(BD). Cells were collected by centrifugation at 1,200 x g for 10 minutes. The pellets 
were resuspended in 1.5 ml Red blood cell lysis buffer with 5 μg/mL Dnase I and 
incubated on ice for 3 minutes. Later on  cell suspension was filled up to 5 ml with 
FAC sorting buffer and then overlaid on the 30%/70% precoll gradient. The tube was 
centrifuged at 1,200 x g for 20 minutes with the acceleration and break off at 4 °C. 
After Percoll gradient centrifugation, mononuclear cells were subjected to FACS 
purification either using immunostaining with fluorescence coupled primary 
antibodies (CD11b-, CD45-, CD31-, CXCR4+ and CD34+) or GFP fluorescence of 
satellite cells from Pax7:ZsGreen mice and Pax7CE/ROSA-YFP mice.  
4.1.2 Isolation single myofibers from the Flexor Digitorum Brevis (FDB) 
muscles 
The FDB muscles from the rear foot of adult mouse were isolated and digested with 
0.2% collagenase II (Roche) in 2ml DMEM medium without serum at 37°C for 60 
minutes. The digestion was stopped by transferring the muscles to 1 ml of the serum-
containing medium (DMEM with 10% FCS and penicillin/streptomycin) in 15ml 
Falcon tube. Then the single myofbers were released by pipetting with a 1 ml 
Eppendorf pipette (tips were cut to a large diameter with blade). The isolated 
myofibers was washed with warm PBS twice and fixed with 4% PFA for further 
immunofluorescence staining.  For culture, single fibers were washed 3 time with 
warm serum-containing medium and cultured in GlutaMAX ™ DMEM medium with 
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20% FCS and FGF (15 μg/μl) in suspension. Half of the medium was replaced with 
fresh culture medium every day. Fixed fibers were stained and the number of satellite 
cells was quantified per fiber. 
4.2 Cell culture 
4.2.1 C2C12 culture 
Mouse C2C12 myoblasts (American Type Culture Collection, (Yaffe and Saxel, 1977) 
were maintained in DMEM supplemented with 10% FCS and 1% 
penicillin/streptomycin at 37 °C and 5% CO2 at a cell concentration between 1.5 X 10
5 
and 1.0 X 106 viable cells/75 cm2. The differentiation medium contained 2% horse 
serum instead of 10% FCS. The cells were passaged by trypsinization (0.5% trypsin 
in 0.5 mM EDTA, Gibco BRL) from the culture plate at 70% confluence. For storage, 
cells were frozen in DMEM supplemented with 20% FCS and 5% (v/v) DMSO and 
kept in liquid nitrogen. 
4.1.2 Culture of satellite cell  
The plates and dishes were coated with matrigel before using. matrigel was gradually 
dissolved on ice and diluted 1:20 in ice cold culture media to coat 3.5-cm dishes. 
Covered the surface of dishes with 1ml matrigel solution, then immediately removed 
the matrigel. Each microliter matrigel solution was used to coat maximum 3 dishes. 
The dishes were placed in 37°C incubator for 1 hour and then in the hood with the lid 
open to air-dry for 1 hour.  To coat 384-well mClear plates (BD Biosciences, Greiner) 
plates, the matrigel was diluted 1:50 in culture media. The surface of each 384 well-
micro plate was covered with 40 μl of matrigel solution. Plates were placed at room 
temperature for 1 hour and then in 37°C incubator for at least 1 hour before the cells 
were seeded.  
FACS-isolated satellite cells suspension was diluted with warm growth medium. 500 
cells were seeded in each well of 384-well plate and 1.0 X 104 cells were seeded in 
one 3.5-cm dish. The medium was changed every day with fresh warm growth 
medium. For Cre recombinase mediated in vitro ablation of Prmt5, the cells were 
culture with 0.4 uM 4-OH-tamoxifen in the growth medium for at least 4 days. 
4.3 in vitro EdU labeling assay 
To determine the proliferating rate of satellite cells, a thymidine analogue, 5-ethynyl-
2'-deoxyuridine (EdU) was used to label active DNA synthesis. Wild type and PRMT5 
knockout satellite cells were cultured on Matrigel-coated 384-well mClear plates (BD 
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Biosciences, Greiner). EdU (Invitrogen) was added to the culture 3 hours before 
fixation in a final concentration of 40 mM. Incorporated EdU is detected with a Click-
iT® EdU Kit. Detection of EdU was done with Alexa Fluor 594 (Invitrogen) following 
standard protocols. Image acquisition and analysis were performed on Keyence 
BIOREVO BZ-9000 microscope. 
4.4 TUNEL assay  
In Situ Cell Death Detection Kit TMR red (Roche) is used to detect apoptotic cells 
based on the principle of TUNEL method. The hallmark of apoptosis is DNA cleavage, 
which may yield double-stranded and single-stranded DNA breaks (nicks). Both 
types of breaks were detected by labeling the free 3'-OH termini with TMR-dUTP, 
which was catalyzed by the enzyme terminal deoxynucleotidyl transferase (TdT). 
Briefly, the cells or the cryosetions were fixed by 4% PFA and permeabilized on ice 
with freshly prepared solution (0.1% triton x-100 in 0.1% sodium citrate) for 2 min. 
After washing with PBS, the samples were incubated with the TUNEL reaction 
solution which contains the Label solution and the Enzyme solution (9:1) at 37°C for 
1 hour. DNase treated sample was used as a positive control. Image acquisition and 
analysis were performed on Keyence BIOREVO BZ-9000 microscope using the 
excitation wavelength in the range of 520-560nm and detection in the range of 570-
620nm. 
4.5 Senescence cell staining 
The senescent cells were detected by the senescence cells histochemical staining 
kit(Sigma). The assay is based on a histochemical staining for β-galactosidase 
activity at pH 6. Under these conditions, β-galactosidase activity is easily detectable 
in senescent cells, but undetectable in quiescent, immortal, or tumor cells. The 
staining is following the standard protocol. The cells were fixed for 7 min at room 
temperature with fixing buffer which contains 2% formaldehyde, 0.2% glutaraldehyde, 
7.04 mM Na2HPO4, 1.47 mM KH2PO4, 0.137 M NaCl, and 2.68 mM KCl. After 
washing with PBS for three times cells were incubated with stain mixture at 37°C 
without CO2 until the cells are stained blue (2 hours to overnight). The cells were 
observed under Keyence BIOREVO BZ-9000 microscope. Blue-stained cells and the 
total number of cells were counted. The percentage of cells expressing β-
galactosidase (senescent cells) was calculated.  
4.6 Freezing and sectioning of muscles and embryos   
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Tibialis anterior and soleus muscles were dissected and placed with one end in 10% 
gum tragacanth on a flat piece of cork. The muscle should extend above the level of 
the gum. The specimen are then inverted and submerged for 10 - 12 seconds in 
isopentane cooled by liquid nitrogen. Very quickly, working on dry ice, wrap the 
frozen muscle in aluminum foil, place the wrapped specimen in a biohazard bag, and 
place it immediately onto dry ice or in a -80°C freezer. Do not allow any opportunity 
for partial thawing. The dated embyos were embedded in OCT compound and frozen 
isopentane cooled by liquid nitrogen. Frozen sections (5-10 μm thick) were prepared. 
Tissues and embryos were sectioned at -20oC using a cryostat (Leica, Germany). 
The cryosections were collected on Vectabond-coated glass slides, dried at room 
temperature and stored at -20oC.  
4.7 Immunofluorescence  
4.7.1 Cells and myofibers staining 
Satellite cells and myofibers were washed with PBS and fixed with 4% 
paraformaldehyde (PFA) in PBS for 10 minutes at room temperature. After washing 
twice with PBS, the cells and myofibers were permeabilized with PBS containing 0.3% 
Triton X-100 for 5 minutes at room temperature and followed with the other three-
time washing with PBS. Then the cells and fibers were blocked with 5% horse serum 
(InvitrogenTM) for 1 hour at room temperature and incubated with the primary 
antibodies overnight at 4oC. The cells and fibers were washed three times with PBS 
with 0.01% Triton X-100 and incubated with the secondary antibody for 1 hour at 
room temperature in dark. After three times of washing with PBS with 0.01% Triton 
X-100, the cells were counterstained with 1 μg/ml DAPI for 2 minutes. The fibers 
were transferred to a glass slide suitable for microscopy. Remove any excess of PBS. 
Apply mounting medium and then add coverslip. Proceed to visualize myofibers 
under a Carl Zeis, Axiophot microscope. The stained cells were kept in PBS and 
analyzed by Keyence BIOREVO BZ-9000 microscope. 
4.7.2 Cryosection staining 
The sections were fixed with cold acetone for 15 minutes at 4 oC and then air dried at 
room temperature for 30 min. After fixation, sections were pretreated with blocking 
solution (5% bovine serum albumin, or mouse IgG blocking solution(M.O.M kit) for 
mouse IgG1 antibody) for 1 hour. The incubation of primary antibody and secondary 
antibody is following the protocol of cell staining.  After counterstained with DAPI, the 
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sections were mounted with Mowiol medium and analyzed by fluorescence 
microscopy on a Carl Zeis, Axiophot microscope.  
4.8 Haematoxylin-eosin staining (H&E) 
H&E staining was performed followed the standard protocol (Fischer et al., 2008). 
Briefly frozen sections were fixed in cold acetone for 5 minutes in Coplin jar and 
completely dried at room temperature for 30 minutes. Afterward the sections were 
rinsed in distilled water and stained in haematoxylin solution (Merck, Germany) for 10 
minutes. After 10 minutes under running tap water the access color was removed. 
Stained sections were additionally stained with Eosin 0.5% (diluted in distilled water) 
for 6 minutes. Sections were dehydrated through 96%, 100%,100% ethanol dilution 
steps. Afterward sections were cleared in xylol 2 times for 10 minutes. At the end 
sections were mounted with Entellan and coverslips. 
4.9 Masson’s trichrome staining 
Trichrome stains are used primarily for distinguishing collagen from muscle tissue. 
The staining was performed using ACCUSTAIN® trichrome staining (Masson) kit. 
Briefly, the sections were mordant in preheated Bouin’s Solution, at 56°C for 15 
minutes and washed in running tap water for 25min to remove yellow color. 
Afterwards, the samples were stained in Working Weigert’s Iron Hematoxylin 
Solution for 5 minutes and washed in running tap water for 5 minutes. Then the 
sections were placed successively in Biebrich Scarlet-Acid Fucshin for 5 minutes, in 
Working Phosphotungstic/Phosphomolybdic Acid Solution for 5 minutes, in Aniline 
Blue Solution for 5 minutes, and in 1% Acetic Acid for 2 minutes. Finally the slides 
were dehydrated through alcohol, cleared in xylene and mounted. 
4.10 RNA extraction  
Total RNA from satellite cells and muscles was isolated using the Trizol reagent 
(Invitrogen). All plastic- and glassware used was rinsed with water containing 0.05% 
DEPC and autoclaved before use to inactivate RNAses. The cell pellet was dissolved 
in 1ml Trizol and incubated at RT for 5 min. 200ul chloroform were added and the 
solution was mixed vigorously for 15 sec, incubated at RT for 2-3 min followed by a 
centrifugation step at 4°C and 12000 g for 20 min. The supernatant was transferred 
to a new tube and well mixed with 500 l isopropanol. After incubation at RT for 5 - 
10 min the solution was centrifuged at 4°C and 12000g for 10 min. The supernatant 
was discarded and the pellet was washed with 70% EtOH (prepared with RNAse-free 
water) followed by a centrifugation at 4°C at 10000 g for 5 min. The resulting pellet 
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was dried and dissolved in 20 μl RNAse free water. RNA concentration was 
measured using Nanodrop (Thermo).  
4.11 RT-qPCR 
1µg RNA was subjected to a reverse transcriptase reaction in the presence of 25 
ng/ml random primers and 2.5 mM dA/C/G/TTP with 10 U/ml SSII reverse 
transcriptase and without enzyme in negative control reactions. The RNA in 10 μl 
RNAse-free water was mixed with the random primers to a final volume of 11 μl and 
incubated at 65°C for 5 min followed by 5 min on ice. After addition of 4 μl 5 x 
firststrand Buffer, 1 μl 0.1 M DDT, 0.5 μl RNAsin, 1ul dNTPs and 1 μl SSII reverse 
transcriptase (200 U/μl), the mixture was incubated for 55 min at 42°C and for 10 min 
at 70°C. 1 μl of the mixture were used in gene-specific PCR reactions. Quantitative 
PCR was performed using the iCyclerTM (Bio-Rad) and ABsoluteTm QPCR SYBR® 
Green Fluorescein Mix (ABgene®, U.K.). For the reaction mix 7 μl of cDNA, 7.5 μl of 
SYBR green and 0.5uM of each primer per reaction were used. A list of the primers 
is supplied in Table 7. For each experiment the amounts of targets and endogenous 
constitutively expressed housekeeping gene (GAPDH or m36B4) was determined 
from the standard curve. The target values (starting quantities) were normalized to 
the endogenous reference: SQtarget/SQGAPDH or SQtarget/SQm36B4. 
4.12 Westerns blotting 
The cultured cells were harvested, washed with ice cold PBS and lysed in cell lysis 
buffer (20 mM Tris (pH 7.5), 400 mM NaCl, 1 mM EDTA, 1 mM EGTA, 1% Triton X-
100, 2.5 mM Sodium pyrophosphate, 1 mM β-glycerophosphate, 1 mM Na3VO4, 1 
μg/ml Leupeptin) for 10 min on ice, followed with the sonication. The concentration of 
the isolated proteins was determined using BCA Protein Assay Reagent (Pierce, 
Rockford, IL). Samples were mixed with 4 x SDS sample buffer and incubated at 
95°C of 10 min. 10 μg whole cell lysate of each sample was loaded on a 10-15 % 
SDS gel, depending on the size of the interested protein. The gel was blotted onto 
nitrocellulose membrane (Millipore, Billerica, MA) and blocked with 5% milk/TBS-T 
1hour at room temperature. The primary antibody was applied over night at 4°C. 
Blots were washed twice for 10 min with TBS-T and blots were incubated with the 
secondary antibody for 1 hr at room temperature. Blots were washed three times for 
10 min with TBS-T. Protein expression was visualized using an enhanced 
chemiluminescence detection system (GE Healthcare, Little Chalfont, United 
Kingdom) and quantified using a ChemiDoc gel documentation system (Bio-Rad). 
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4.13 Chromatin immunoprecipitation (ChIP) 
100,000 satellite cells were cross-linked with 1% formaldehyde for 10 min, and then 
were quenched by 0.125 M glycine. The cross-linked cells were washed with ice-cold 
PBS for three times and spun down at 1200 g. The cell pellets xwere snap-frozen in 
liquid nitrogen, and stored at -80°C before use.  
   The pellets were re-suspended in 150ul Nuclear Lysis Buffer with protease 
inhibitors and incubate for 10 min on ice.  Sonication was carried out with 
Bioruptor( Diagenode), which was used at energy level high and pulses of 30 sec. 
The number of pulses depended on the cell type and the amount of chromatin in the 
sample. After sonication, 5 μl of the sheared chromatin was reverse cross-linked in 
50ul 10% Chelex/H2O, then loaded on a 2% agarose gel to check the fragment sizes, 
which should be around 300bp.  
   DNA concentration in the sheared chromatin was determined with Nanodrop 
(Thermo) and samples were diluted to 50 μg/ml DNA and split into portions of 1 ml in 
1.5 ml eppendorf tubes. The tubes were either subjected to immunoprecipitation or 
stored at -80°C until further use. Fragmented, precleared chromatin lysate was 
incubated overnight with indicated antibodies: Histone H3 (Abcam), H3R8me2s 
(Novus) and PRMT5 (Active Motif), Rabbit IgG(Diagenode). And then was mixed with 
pre-blocked protein A agarose beads for 2 hours. The beads were spin down and 
washed with Low Salt buffer, High Salt buffer, LiCl2 buffer and TE buffer. Finally, the 
reverse cross-linking was performed in 10% Chelex. The supernatant was used for 
real-time PCR. Primers used for ChIP-qPCR are listed in Table 7. 
4.14 ChIP sequencing 
The proliferating and 2-day differentiated C2C12 cells were cross-linked with 1% 
formaldehyde/PBS for 10 min, and then were quenched by 0.125 M glycine. The 
cross-linked cells were washed with ice-cold PBS for three times. Spin down and 
resuspend the cells in ice-cold Cell Lysis Buffer with protease inhibitor, and stay on 
ice for 10min. The cells were pelleted and snap-freezed in liquid nitrogen, and stored 
at -80°C before use.  
   The pellets were re-suspended in 150ul Nuclear Lysis Buffer with protease 
inhibitors and incubate for 10 min on ice.  Sonication was carried out with Bioruptor 
(Diagenode), which was used at energy level high and pulses of 30 sec. The number 
of pulses depended on the cell type and the amount of chromatin in the sample. After 
sonication, 5 μl of the sheared chromatin was reverse cross-linked in 50ul 10% 
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Chelex/H2O, then loaded on a 2% agarose gel to check the fragment sizes, which 
should be around 300bp.  
   DNA concentration in the sheared chromatin was determined with Nanodrop 
(Thermo) and samples were diluted to 100 μg/ml DNA and split into portions of 1 ml 
in 1.5 ml Eppendorf tubes. The tubes were either subjected to immunoprecipitation or 
stored at -80°C until further use. Fragmented, precleared chromatin lysate was 
incubated overnight with indicated antibodies: Histone H3 (Abcam), H4K20me1 
(Abcam), H4K20me2 (Abcam) and H4K20me3 (Abcam), then was mixed with pre-
blocked protein A agarose beads for 2 hours. The beads were spun down and 
washed with Low Salt buffer, High Salt buffer, LiCl2 buffer and TE buffer. After last 
wash, remove the last traces of buffer. Elution was carried out in 500ul freshly 
prepared IP Elution Buffer (100mM NaHCO3, 1%SDS) for 30min in room 
temperature on a rotating wheel. Transfer the supernatant to a clean tube. Reverse 
the crosslinking by adding NaCl to final concentration of 0.3M and shaking at 65° for 
6h, then with 20ug/ml RNase (DNase free) at 37° for 1h, followed with 0.01M EDTA, 
0.04M Tris pH6.8 and Proteinase K, at 45° for 1h. Finally the ChIPed DNA was 
purified by the mini-elute PCR kits (Qiagen). Measure the DNA concentration using 
Qubit® Fluorometric Quantitation (Life Science). Sequencing was performed on an 
Illumina HiSeq 2000 following a standard protocol. 
   ChIP-seq reads were converted to fastq format and aligned to a precompiled mm9 
reference index with BOWTIE (Langmead, 2010). Peaks calling was performed using 
MACS (Zhang et al., 2008) . All downstream analyses were done in R/BioConductor 
(http://www.bioconductor.org) which includes the multiple packages: 
GenomicRanges, GenomicFeatures and chipseq. 
4.15 Transgenic mice 
Pax7CreERT2/Prmt5fl/fl mice (Prmt5sKO) were obtained by breeding knock in Pax7CreERT2 
mice with animals bearing floxed Prmt5 alleles (EUCOMM). Genomic DNA was 
prepared from tail or muscle tissue and genotyping was performed by polymerase 
chain reaction (PCR), as previously described. Specific oligonucleotide sequences 
used as primers for PCR are listed in Table 6.  
4.16 Tamoxifen injections 
A single pulse of 2 mg Tamoxifen (Sigma, T5648) in Miglyol® 812 (Caesar & Loretz 
GmbH) was given to adult mice (7-9 weeks old). Inducible mice were preceded for 
muscle regeneration assay after one week of the Tamoxifen administration. 
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4.17 Muscle regeneration assay 
Before the treatment of muscle injury mice were anaesthetized intraperitoneally with 
2,2,2-tribromoethanol. The stock solution of 1 g/ml was made in isobutane. The 
working solution for injections contained 120 μl of the stock solution in 10 ml of sterile 
PBS buffer (12 mg/ml). To anaesthetize mice 25 μl of the working solution per 1 g of 
body weight was injected intraperitoneally using a 27-gauge needle. To introduce a 
muscle injury, 50 μl of 0.06 mg/ml cardiotoxin from Naja mossambica mossambica 
(Sigma, Germany) in 0.9% NaCl was injected into the tibialis anterior of adult mice 
using a 27-gauge needle and a 1 ml syringe. The needle was inserted deep into the 
muscle longitudinally towards the knee from the ankle. The anterior tibial muscles 
were analyzed 7 and 14 days after the injectio. Cardiotoxin (Sigma) was injected into 
tibialis anterior muscles in a volume of 50 µl. 
4.18 Magnetic resonance imaging  
All MRI experiments were performed on a 7.0T superconducting magnet (Bruker 
Biospin, Pharmascan, 70/16, 16 cm; Ettlingen, Germany) equipped with an actively 
shielded imaging gradient field of 300 mT/m. The frequency for the 1H isotope is 
300.33MHz. A 60 mm inner diameter linear polarized 1H volume resonator was used 
for RF pulse transmission and signal reception (Bruker Biospin). Localizer images 
were acquired using a spin-echo sequence and corrections of slice angulation were 
performed, if necessary. RARE-(Rapid Acquisition with Relaxation Enhancement) 
sequences (TR=2500 ms, TE=36.7 ms slice thickness=1 mm) in axial and coronal 
orientation were used to determine exact positioning of the lower part of the mouse 
body. Afterwards a coronal MSME-(Multi-Slice-Multi-Echo) spin-echo-sequence with 
an echo time TE=8,6 ms, repetition time TR=453 ms, a field of view FOV=7x7 cm², 
matrix size MTX=512x256 and a slice thickness of 1 mm was recorded. For 
volumetric quantification of fat and muscle tissue we used a plugin developed at our 
institute for the image processing software ImageJ. A list of anatomically defined 
landmarks are set by the operator and used to derive tissue specific signal intensity 
thresholds and to define the region of interest for intensity sensitive region growing 
segmentation. The resulting tissue voxel volumes inside the region of interest is 
counted and returned as cubic millimeters for each tissue class. Mice were measured 
under volatile isoflurane (1.5 – 2.0 % in oxygen and air with a flow rate of 1.0 L/min) 
anesthesia; the body temperature was maintained 37°C by a thermostatically 
regulated water flow system during the entire imaging protocol. 
4.19 Calcium phosphate transfection 
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The production of the self-inactivating lentiviral particles was performed in HEK293T 
cells with standard protocol (The RNAi Consortium (TRC) Broad InstituteThe RNAi 
Consortium). shRNA-encoding vector (Table 7.) with psPAX2 the plasmid for the 
packaging genes (gag, pol, and rev), encoding and pMD2.G were co-transfected in 
HEK293T cells. A day before transfection, 7 × 105 of HEK293T cells were plated per 
well of a 6-well plate plated. For transfection, 1 μg of shRNA lentiviral control vector 
(pLKO.1) and 0.9 μg and 0.1 μg of the packaging virus pPAX2 or pMD2.G with MilliQ 
H2O were mixed in a total volume of 450 μl. After addition of 50 μl of 2M CaCl2 and 
500 HBS buffer, the mixture was added dropwise to the medium where the cells are. 
The transfection culture plates were gently agitated and incubated at 37 oC. 
Transfected cells were incubated for 18 hours. Media was changed to remove the 
transfection reagent and replaced by high serum growth media. Afterward cells were 
sequentially incubated for 24 hours before harvesting the viral-containing media at 
24-48 hours post infection. All subsequent steps were according to the Gene 
Technology Act Made (GenTG) under the security measures of the security level S2 
4.20 Lentivirus infection of C2C12 cells 
Lentivirus infection was performed with minor modification from standard protocol 
(The RNAi Consortium (TRC) Broad Institute, The RNAi Consortium). FACS sorted 
SCs were cultured individually in 30% FCS GlutaMAX™ media supplemented with 
PenStrep on matrigel-coated 96 well µClear plates (BD Biosciences, Greiner) as 
described previously (Ustanina et al., 2007). After one day of culturing, cells were 
infected with the lentivirus-containing media with 2μg/μl polybrene. Medium was 
removed and replaced by 30% FCS GlutaMAX™. 75-85% infection efficiency was 
observed by YFP expression at 3 days after infection. 
4.21 Immunprecipitaion 
C2C12 cells were washed with ice-cold PBS, resuspended in hypotonic buffer 
containing 0.1% Triton X-100. After incubation on ice for 7 minutes, nuclei were 
centrifuged at 1,500 x g for 5 minutes, 4 oC. Nuclei were lysed in IP buffer (20 mM 
Tris-HCl, pH 8.0, 400 mM NaCl, 1 mM EDTA, 1 mM EGTA, 1% Triton X-100, 
complete protease inhibitor cocktail) at 4 oC for 10 minutes. The lysate was sonicated 
with bioruptor for 15 min and cleared by centrifugation at 16,000 x g for 10 min, 4 oC. 
Nuclear extracts were pre-cleared by incubation with protein A/G Sepharose 
(Amersham) at 4 oC for 1 hour. After pre clearing, the lysates were incubated with HA 
beads for 4 hour at 4 oC. After successive washing with wash buffer (20 mM Tris-HCl, 
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pH 8.0, 200 mM NaCl, 1 mM EDTA, 1 mM EGTA, 1% Triton X-100), bound proteins 
were eluted from beads in 1 x SDS loading buffer and analyzed on western blots. 
4.22 Stable isotope labeling by amino acids in cell culture 
C2C12 cells that are ectopically expressing PR-Set7-HA were grown in heavy 
medium (Arg8, Lys10), while C2C12 cells with empty vector were labeled with nature 
arginine and lysine (light, Arg0, Lys0). The cells were cultured for at least six 
passages in heavy and light media to metabolically incorporate heavy amino acids 
into synthesised proteins. Growth media were replaced with fresh media every three 
days over a period of a week. Affinity purification of the HA-tagged PR-Set7 was then 
performed separately following the protocol described above and immunoprecipitates 
were mixed from both cell lysates within proliferating and differentiating conditions 
and resolved on a 4–20% SDS–PAGE (NuPAGE, Life Technologies). The gel was 
stained with Coomassie blue, cut into 15 slices and processed for mass 
spectrometric analysis using standard in gel procedure. Briefly, In-gel digests 
(components from Sigma) were performed with the protease LysC (Wako Chemicals 
GmbH, Neuss, Germany), and peptides were loaded onto STAGE-tips for 
subsequent MS analysis after extraction. The mass spectrometry and data analysis 
were performed as described before (Looso et al., 2010). 
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5 RESULTS 
5.1 PRMT5 expression in adult muscle stem cells and during 
embryonic development  
PRMT5, histone symmetric arginine dimethytransferase catalyzing histone H3R8 and 
H4R3 methylation, has previously been shown to be required for maintaining 
pluripotency of embryonic stem cells and controlling proliferation of neuronal 
progenitor cells (Bezzi et al., 2013; Eckert et al., 2008; Tee et al., 2010). To 
investigate the role of PRMT5 in developmental myogenesis and/or regenerative 
myogenesis, I firstly monitored PRMT5 expression in quiescent muscle stem cells 
and differentiated myocytes by performing immunofluorescence assay using freshly 
isolated myofibers. PRMT5 is highly enriched in Pax7 expressing quiescent satellite 
cells but not in differentiated myonuclei, suggesting that PRMT5 may be required for 
satellite cell function (Figure 5.1A). Furthermore activation and differentiation of 
quiescent satellite cells purified by FACS sorting from Pax7-ZsGreen reporter mice 
(refxx) correlates with reduction of PRMT5 expression together with down-regulation 
of Pax7 expression and up-regulation of Myogenin expression, a molecular marker 
for early myogenic differentiation (Figure 5.1B).  
   Given that adult satellite cells originate from a population of highly proliferative 
Pax7+/MyoD+ muscle progenitors during embryonic and fetal muscle development, I 
then analyzed the expression profile of PRMT5 during embryonic development. A 
transgenic mouse line carrying one allele of Prmt5tm2a(EUCOMM)Wtsi (Prmt5tm2a/+), which 
contains an IRES:LacZ tracing cassette and a FRT promoter-driven neo cassette 
inserted into the sixth intron of Prmt5, allowed me to detect expression of PRMT5 
during embryonic development in vivo. The Prmt5tm2a/+ mice were crossed with 
C57Bl/6j wild type mouse and staged embryos were dissected for whole mount lacZ 
staining. While wild type littermates did not show LacZ staining, mice with transgenic 
allele of LacZ within Prmt5 loci showed strong expression of E9.5 embryos with 
decreased staining in the E11.5 especially in the somites, suggesting that down-
regulation of PRMT5 in late stages of developmental myogenesis. I concluded that 
PRMT5 is highly enriched in quiescent satellite cells in adult skeletal muscle and the 
expression is reduced during embryonic myogenesis and upon differentiation in vitro.     
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5.2 PRMT5 controls satellite cell homeostasis and muscle 
regeneration  
To address the physiological function of PRMT5 in adult satellite cells, I adopted an 
inducible knockout system due to the early embryonic lethality upon PRMT5 ablation 
(Tee et al., 2010). The Prmt5tm2a/+ mouse was firstly crossed with a FLP recombinase 
mouse line leading to deletion of FRT cassette. The resulting Prmt5fl/+ mice were 
interbred to generate homozygous Prmt5fl/fl mice, which were further crossed with 
tamoxifen (TAM) inducible Pax7CreERT2(Pax7CE) mice (Lepper et al., 2009). The 
resulting Pax7CE/Prmt5fl/fl mouse strain (hereafter referred to as PRMT5 satellite cell 
Figure 5.1 PRMT5 is highly enriched in satellite cells 
(A) Immunofluorescence assay showing PRMT5 (red) is highly expressed in Pax7+ satellite 
cells (green) from freshly isolated FDB myofibers. Scale bar indicates 20 μm. 
(B) RT-qPCR analysis of Prmt5, Pax7, MyoD and MyoG expression in quiescent satellite cells 
(QSCs), activating satellite cells (ASCs) and differentiated myotubes. Expression levels of 
distinct mRNAs are normalized to mRNA of GAPDH.  
(C) Schematic of Prmt5 knockout first allele (Prmt5
tm
) from EUCOMM. The ‘knockout-first’ 
allele (tm2a) contains an IRES:lacZ trapping cassette and a human beta-actin promoter--
driven neo cassette between two FRT sites, inserted into the sixth intron of Prmt5 . The 
exon seven is flanked by loxP site. 
(D) Whole mount LacZ staining showing Prmt5 expression at embryonic day 9.5 (E9.5) and 
day 11.5 (E11.5) in wild type and Prmt5
fl/+ 
embryos. 
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specific knockout mouse, Prmt5sKO) allows inducible inactivation of PRMT5 by 
intraperitoneal administration of TAM and enabled us to specifically probe the role of 
PRMT5 in satellite cells in adult mice (Figure 5.2.1A).  
 
 
 
 
Figure 5.2.1 PRMT5 is dispensable for short-term satellite cell maintenance and muscle 
integrity 
(A) Schematic outline of generation of Prmt5 flox line. The ‘knockout-first’ allele are converted 
by FLP-mediated recombination in vivo to a conditional allele, which is referred to as 
Prmt5
fl
. Pac7
CreERT2
 deletes the floxed exon 7 of the Prmt5
fl
 allele to generate a frameshift 
mutation upon tamoxifen induction. Red arrow head indicates loxP site. P1/P2 primer pair 
covers upstream and downstream of FRT site, whereas P3/P4 primer pair locates outside 
of two loxP sites and could be used to monitor Cre mediated recombination. 
RESULTS 
 
50 
 
5.2.1 PRMT5 is dispensable for short-term maintenance of muscle 
homeostasis. 
2-month old Prmt5sKO/Pax7-ZsGreen (n=3) and Pax7CE/Prmt5fl/+/Pax7-ZsGreen 
(referred to as Control or Ctrl later) littermates (n=3) were treated with 3mg 
Tamoxifen per 40g body weight for 5 consecutive days followed by 10 additional 
injections every other day (Gunther et al., 2013) (Figure 5.2.1B). Recombination of 
the Prmt5 locus was efficient as assessed by PCR genotyping (Figure 5.2.1C) and 
RT-PCR (Figure 5.2.1D) using the FACS purified satellite cells from each group of 
mice. Interestingly, TAM treated Prmt5sKO mice remained viable and displayed no 
obvious short-term phenotypes under physiological conditions 21 days after 
treatment (Figure 5.2.1D). No significant change of bodyweight and no morphological 
alterations of skeletal muscle tissue were observed (Figure 5.2.1F&G). 
Cryosectioned tibialis anterior (TA) muscle and freshly isolated flexor digitorum brevis 
(FDB) myofibers of control and Prmt5sKO littermates showed no difference in satellite 
cell numbers, suggesting that PRMT5 is not required for short-term maintenance of 
muscle homeostasis under normal physiological conditions (Figure 5.2.1H&I).  
 
5.2.2 PRMT5 is required for muscle regeneration and long-term 
maintenance of satellite cells pool. 
Satellite cells are responsible for muscle integrity and repair after chronic and acute  
 
 
(B) Schematic of experimental procedure through which Prmt5 exon 7 could be deleted upon 
tamoxifen administration for 3 weeks. 
(C) Representative genomic PCR analysis using primer pair P3/P4 from FACS sorted satellite 
cells showing Pax7
CE
 mediated deletion of exon 7 in Prmt5
sKO
 mice (n=3) after tamoxifen 
administration. P1/P2 PCR is used as an internal control. 
(D) Semi-quantitative RT-PCR analysis showing a dramatic reduction of Prmt5 mRNA in 
FACS-sorted satellite cells from Prmt5
sKO
 mice (n=3) as compared with control littermates 
(n=3). m36B4 mRNA is used as an internal control. 
(E) Representative image of control and Prmt5
sKO
 mouse 3 weeks after tamoxifen 
administration. 
(F) Bodyweight of control and Prmt5
sKO
 mice (n=3) upon tamoxifen administration. The error 
bars represent standard deviations of the mean (t-test: p >0.1). 
(G) Hematoxylin&Eosin (H&E) staining of TA and Soleus muscle after tamoxifen treatment in 
control and Prmt5
sKO
 mice (n=3). Scale bar indicates 50 μm. 
(H) &(I) Immunofluorescence assay of Pax7
+
 cells in TA cryo-sections (H) or in freshly isolated 
FDB myofibers (I) showing no difference of satellite cell numbers between control and 
Prmt5
sKO
 mice in vivo 3 weeks after tamoxifen treatment. The number of Pax7
+ 
per 10mm
2
 
section area (H) or 100 myofibers (I) is counted. Error bars represent standard deviations 
of the mean (t-test: p>0.5, n=3). 
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muscle injury (Gunther et al., 2013; Sacco et al., 2010). Therefore I first investigated 
whether PRMT5 deficient satellite cells still contribute to muscle regeneration upon 
acute muscle injury in vivo. To this end, TAM treated Prmt5sKO and control littermates 
were subjected to muscle injury via CTX injection into the TA muscle (Figure 5.2.2A). 
In control animals I noted a robust regenerative response resulting in the formation of 
regenerated muscle fibers with centrally located nuclei 7 days, 14 days and 4 months 
after injury (Figure 5.2.2B). Strikingly, muscle regeneration was completely abolished 
at all of the indicated time-points in conditionally ablated Prmt5sKO mice. Hardly any 
Figure 5.2.2 PRMT5 is required for long-term maintenance of satellite cell pool and 
muscle regeneration upon acute muscle injury in vivo 
(A) &(B) Immunofluorescence assay of Pax7+ cells in cryo-sections from TA muscle (A) or in 
freshly isolated FDB myofibers (B) revealing a reduced number of satellite cells from 
Prmt5
sKO
 mice compared with control littermates 4 months after tamoxifen administration. 
The number of Pax7
+ 
per 10mm
2
 section area (A) or per 100 fibers (B) is counted. Error 
bars represent standard deviations of the mean (t-test: ****p < 0.0001; *p < 0.05; n=4).  
(C) Schematic of short and long term muscle regeneration assay upon acute muscle injury in 
control and Prmt5
sKO
 littermates (n=3) upon tamoxifen administration for 3 weeks. TA 
muscle injury was induced by cardiotoxin (CTX) injection 5 days after initial tamoxifen 
injection and muscle regeneration was analyzed at different time points as indicated. 
(D) &(E) H&E staining (D) and Trichrome staining (E) of TA muscle showing impaired muscle 
regeneration and fibrosis of injured muscle in Prmt5
sKO
 mice as compared to control 
littermates (n=3) after CTX injection at 7 days, 14 days and 4 months. Scale bar indicates 
50 μm. 
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intact muscle fibers could be detected via H&E staining (Figure 5.2.2B), which went 
along with a massive increase of fibrotic tissue as visualized via Masson’s Trichrome 
staining (Figure 5.2.2C). To address the role of PRMT5 in long-term maintenance of 
satellite cell pool, I performed immunofluorescence assay to monitor Pax7 positive 
satellite cells on the cryosections of TA muscles 4 months after tamoxifen 
administration. Significant reduction of satellite cell numbers from Prmt5sKO mice was 
revealed as compared to control mice (Figure 5.2.2D).  Moreover, the numbers of 
satellite cells on the freshly isolated FDB myofibers were also reduced upon PRMT5 
knockout (Figure 5.2.2E). Taken together, these findings demonstrated that PRMT5 
is not required for short-term maintenance of the satellite cell pool but is essential for 
long-term satellite cell maintenance and muscle regeneration upon acute muscle 
injury in vivo. 
 
5.3 Loss of PRMT5 in a muscle regenerative environment 
results in decreased muscle mass and depletion of muscle 
stem cell pool 
The failure of maintaining SC pool after long-term treatment together with the loss of 
muscle regenerative potential upon acute muscle injury in PRMT5 mutant mice in 
vivo support the idea that PRMT5 is required for satellite cell expansion and/or 
replenishment of the muscle stem cell niche in adult mice. To further prove this, I 
generated satellite cell specific PRMT5 knockout mice in a constant regenerative or 
activated environment by crossing Prmt5sKO with Dmdmdx mice and analyzed muscle 
integrity and satellite cells within double knockout mice after long-term treatment with 
tamoxifen. Mdx mice are commonly used animal model for Duchenne muscular 
dystrophy characterized by a constant muscle degeneration/regeneration cycles, and 
constitutive activation and turnover of satellite cells. Importantly, despite constant 
muscle degeneration this histological phenotype is macroscopically characterized by 
a pronounced muscle hypertrophy in adult mdx mice (Pastoret and Sebille, 1993). 
The Prmt5sKO/mdx and control mice were treated with TAM for 3 weeks starting at the 
age of 8 weeks and monitored for bodyweight every week until they were sacrificed 
(Figure 5.3A).  While PRMT5 deficient mice and mdx mice progressively gained 
weight, Prmt5sKO/mdx mice failed to increase the bodyweight any more after TAM 
treatment (Figure 5.3B) and were smaller in size (Figure 5.3C). Consistently, MRI 
measurements revealed a massive decrease in muscle volume of Prmt5sKO/mdx  
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Figure 5.3 Loss of PRMT5 during chronic muscle injury results in decreased muscle 
mass and depletion of muscle stem cell pool  
(A) Schematic of the experimental procedure showing control, Prmt5
sKO
, mdx and 
Prmt5
sKO
/mdx littermates for 3 weeks tamoxifen administration followed by additional 4 
months maintenance. 
(B) Bodyweight measurement of the indicated mice for 4 months showing Prmt5
sKO
/mdx mice 
stop gaining body weigh after tamoxifen administration. 
(C) Prmt5
sKO
/mdx mice showing smaller body size as compared with control, mdx and 
Prmt5
sKO 
mice 4 months after tamoxifen administration.  
(D) MRI measurements of muscle mass of control, Prmt5
sKO
, mdx and Prmt5
sKO
/mdx 
littermates 4 months after tamoxifen administration. Quantification of muscle volume is 
shown on the right. Error bars represent standard deviations of the mean (t-test: 
****p<0.0001, **p < 0.01, ns P>0.05). 
(E) &(F) Masson’s trichrome staining showing Prmt5
sKO
/mdx mice have thinner diaphagram 
muscle (E) and more fibrosis in the soleus muscle (F) as compared with control, mdx and 
Prmt5
sKO 
mice 4 months after tamoxifen administration. Scale bar indicates 400 μm. 
(G) Immunofluorescence assay of Pax7+ cells in TA cryo-sections of indicated mice revealing 
a reduction of satellite cells in the muscle from Prmt5
sKO
/mdx mice as compared with both 
control and mdx littermates. The number of Pax7
+ 
cells per 10mm
2
 section area is 
counted. Error bars represent standard deviations of the mean (t-test: **p < 0.01, ns 
P>0.05, n=3). 
(H) H&E staining of TA muscle showing more hypertrophic myofibers without central nuclei in 
the Prmt5
sKO
/mdx mice as compared to mdx mice. Quantification is shown on the right. 
Error bars represent standard deviations of the mean (t-test: ***p<0.001, ns P>0.05, n=3) 
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(Figure 5.3D) but not in PRMT5 single knockout mice and mdx mice, demonstrating 
that PRMT5 is required for long-term maintenance of muscle mass during the chronic 
muscle injury. These mice were sacrificed at the age of 6 months shortly before the 
Prmt5sKO/mdx mice died. Masson’s trichrome staining revealed a strong increase of 
fibrosis in the soleus muscle compared to Prmt5sKO and mdx mice (Figure 5.3F). 
Notably diaphragm muscles from double mutant mice 3 months after TAM 
administration underwent dramatic pathological changes, suggesting that respiratory 
failure might be the main cause of premature death of double mutant mice (Figure 
5.3E). Accordingly, both Prmt5sKO and Prmt5sKO/mdx displayed a decreased number 
of Pax7 positive satellite cells (Figure 5.3G) compared to controls clearly supporting 
the idea that satellite cells require PRMT5 to replenish the muscle stem cell pool and 
to maintain muscle mass during regeneration. 
 
5.4 PRMT5 controls satellite cell proliferation, differentiation 
and survival 
Regeneration of skeletal muscle depends mainly on adult satellite cells. Upon muscle 
injure, quiescent SCs are activated, enter the cell cycle, and give rise to a population 
of muscle precursors that proliferate (Pax7+MyoD+), differentiate (Pax7-MyoG+) and 
then fuse to form new fibers allowing muscle architecture restoration. In parallel, a 
subset of SC is able to return to its quiescent state, thereby replenishing the initial 
pool and allowing repeated repair of the tissue (Figure 5.4.1A) (Buckingham and 
Rigby, 2014; Rudnicki et al., 2008; Zammit et al., 2006). To address PRMT5 
mediated cellular mechanisms responsible for satellite cell reduction and impaired 
muscle regeneration in Prmt5sKO mice, I dissected the function of PRMT5 in satellite 
cell activation, proliferation and differentiation. 
5.4.1 PRMT5 is required for the proliferation of satellite cells 
To examine whether PRMT5 is required for satellite cell proliferation, satellite cells 
were sorted from TAM treated control and Prmt5sKO mice, cultured in vitro for three 
days and pulse-chased with EdU for three hours before analysis. PRMT5 deficient 
SCs showed a dramatic reduction of the number of EdU-incorporating proliferating 
cells, indicating abrogation of satellite cell self-renewal (Figure 5.4.1B). Furthermore 
ex vivo myofiber culture of TAM treated Prmt5sKO and control littermates showed 
myogenic colonies of self-renewing Pax7 positive satellite cells in control SCs (28±3) 
while Pax7 expression was still apparent but almost no colonies were formed in 
myofibers from Prmt5sKO mice (1= ±1) (Figure 5.4.1D) demonstrating that PRMT5 
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deficient SCs failed to proliferate and re-enter the cell cycle. In addition, gain of 
function assays demonstrated that overexpression of PRMT5 in wild type satellite 
cells in vitro increased EdU-incorporated satellite cells compared to control cells 
(Figure 5.4.1C). In aggregate these data indicated that PRMT5 is indispensable for 
satellite cell proliferation. 
 
 
 
Figure 5.4.1 PRMT5 is required for SC proliferation  
(A)Model depicting satellite cell homeostasis control and muscle regeneration. 
(B)EdU incorporation assay showing an impaired satellite cell proliferation upon PRMT5 
deletion. Quantitation of the percentage of EdU+ cells within Pax7+ cells isolated from 
Prmt5
sKO
 mice as compared to control mice. (unpaired t-test: **P<0.01,n=5) Scale bars 
indicate 50 μm. 
(C)EdU incorporation assay showing an increased satellite cell proliferation upon 
overexpressing Prmt5. Quantitation of the percentage of EdU+ cells from Pax7+ cells 
infected with lentivirus overexpressing PRMT5 as compared to control lentivirus. Error 
bars represent standard deviations of the mean. (unpaired t-test: **P<0.01,n=5) 
(D)Immunofluorescence assay of Pax7 positive colony in 3-day cultured FDB myofibers from 
control and Prmt5
sKO
 mice. Totally Pax7 positive colonies from 100 myofibers are counted. 
Quantification of Pax7 positive colonies in total YFP
+
 cells is shown on the right. Error bars 
represent standard deviations of the mean (t-test: **p < 0.01; ***p < 0.001,n=3). Scale bars 
indicate 50 μm. 
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5.4.2 PRMT5 is required for satellite cell differentiation 
The impairment of satellite cell proliferation upon PRMT5 ablation prompted me to 
investigate the fate of PRMT5 deficient SC in adult muscle by lineage tracing 
approach in control and Prmt5sKO mice in which the YFP-reporter transgene is 
integrated into the Rosa26 locus. Cre recominase expression in Pax7+ satellite cells 
leads to remove of the floxed-STOP sequence in the ROSA26 locus leading to 
expression of YFP fluorescent protein upon TAM induction. Satellite cells and their 
derived progeny then will be permanently labeled by YFP based on the constitutive 
expression from the Rosa26 locus (Figure 5.4.2A). After 3-week TAM administration, 
FDB myofibers were isolated from the control and Prmt5sKO mice and cultured in vitro 
for 3 days. Notably, PRMT5 deficient progeny identified by an anti-YFP antibody 
were still capable of expressing MyoD indicating that SC activation is normal (Figure 
5.4.2B). Along this line in vitro assay of YFP+ cells sorted from Prmt5sKO and control 
littermates did not show any difference of MyoD expression after three-day culture as 
well (Figure 5.4.2C). 
 
 
  
 
Figure 5.4.2 PRMT5 is required for satellite cell differentiation 
(A) Breeding scheme of Pax7
CreERT2
:Prmt5
fl/fl
 mouse with Rosa26-YFP reporter mouse. 
(B) &(C) Immunofluorescence assay of double YFP/MyoD (B) and YFP/MyoG (C) positive 
cells in 3-day cultured FDB myofibers from control and Prmt5
sKO
 mice. Quantification of 
the ratio of MyoD
+
/YFP
+
 (B) and MyoG
+
/YFP
+ 
(C) in total YFP
+
 cells is shown on the right. 
Error bars represent standard deviations of the mean (t-test: **p < 0.0, ***p < 0.001). Scale 
bars indicate 50 μm. 
(D) Immunofluorescence assay of MyoD positive cell in 3-day cultured YFP postive cells from 
TAM treated control and Prmt5
sKO
 mice. Quantification of percentage of MyoD+ cells in 
total cells is shown on the right. Error bars represent standard deviations of the mean 
(t-test: ns p > 0.5).  Scale bar indicates 50 μm.  
(E) Immunofluorescence assay of MyoG positive cells in 2-day differentiating YFP positive 
cells from control and Prmt5
sKO
 mice. Quantification of percentage of MyoG
+
 in total cells 
is shown on the right. Error bars represent standard deviations of the mean (t-test: ****p < 
0.0001). Scale bar indicates 50 μm. 
(F) Immunofluorescence assay of MF20 positive cells in 2-day differentiating YFP positive 
cells from control and Prmt5
sKO
 mice.  Quantification of red area per nuclear is shown on 
the right. Error bars represent standard deviations of the mean (t-test: ***p < 0.001). Scale 
bar indicates 50 μm. 
(G) Representative images from TUNEL assay showing increased apoptotic cells in PRMT5 
deficient cells as compared to control cells after 2-day differentiation. Quantification of 
percentage of TUNEL positive cells in proliferating and differentiating cells is shown on the 
right. Error bars represent standard deviations of the mean (t test: **p < 0.01, ns p>0.05, 
n=3). Scale bar indicates 50 μm. 
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  However when myofibers were stained with an antibody against MyoG, which is an 
early marker of muscle stem cell differentiation, I observed reduction of the ratio of 
MyoG+/YFP+ cells in PRMT5 deficient progeny indicating that lack of PRMT5 
inhibited differentiation of SCs (Figure 5.4.2D).  Consistently in vitro assay of YFP+ 
cells sorted from Prmt5sKO and control littermates indicated an impaired muscle cell 
differentiation in mutant mice monitored by MyoG and myosin heavy chain 
expression (Figure 5.4.2E&F).  
Importantly cell apoptosis analysis showed that while there were no detectable 
apoptotic cells in proliferative medium in both wild type and mutant mice, upon 
differentiation significantly more apoptotic cells were detected in mutants (Figure 
5.4.2G), indicating that PRMT5 is required for SC survival during differentiation. In 
aggregate, these data demonstrated that PRMT5 is necessary for muscle stem cell 
proliferation, and required for cell differentiation and survival, cellular mechanisms 
responsible for long-term muscle stem cell maintenance and muscle regeneration 
upon acute or chronic muscle injury.  
 
5.5 PRMT5 is dispensable for myofiber maturation 
To investigate whether PRMT5 plays a role in the late stage of differentiation and 
myofiber maturation during skeletal muscle regeneration, Prmt5fl/fl mice were crossed 
with HSACreERT2 mice, where Cre mediated recombination occurs only in postmitotic 
myofibers but not in satellite cells (Lai et al., 2004). The resulting HSACreERT2/Prmt5fl/fl 
mouse strain allows specific inactivation of PRMT5 in differentiated myotubes upon 
tamoxifen administration during muscle regeneration. TAM treated TA muscles from 
wild type, HSACreERT2/Prmt5fl/+ and HSACreERT2/Prmt5fl/fl littermates were subjected to 
CTX injection (Figure 5.5A). 14 days after injury, the size of TA muscle were normal 
between injured and uninjured muscles from wild type, HSACreERT2/Prmt5fl/+ and 
HSACreERT2/Prmt5fl/fl mice indicating full regeneration of skeletal muscle (Figure 5.5B). 
Furthermore, myofibers with central nuclei in all mice were detected in cross-sections 
by hematoxylin and eosin (H&E) staining (Figure 5.5C, 1X injury). Thus, the findings 
demonstrated that PRMT5 is dispensable for the late stage of muscle differentiation 
and myofiber maturation during muscle regeneration. Taken together by using 
different Cre lines, I could show that inactivation of PRMT5 in satellite cells but not in 
differentiated myocytes impairs muscle regeneration.  
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5.6 Molecular mechanism underlying PRMT5 function in 
satellite cell proliferation 
 5.6.1 Transcription up-regulation of cell cycle inhibitor p21 gene upon 
PRMT5 deletion in satellite cells 
Satellite cell homeostasis is controlled by transitions of cells between quiescence and 
proliferation, and the hallmark of the proliferating population is progression through 
the cell cycle (Cheung and Rando, 2013). The strong inhibition of satellite cell 
proliferation upon PRMT5 ablation prompted us to investigate cell cycle regulation by 
PRMT5, which led to the identification of the cell cycle inhibitor p21 as a potential 
PRMT5 target gene. p21 belongs to the Cip/Kip family of G1-specific cell cycle 
dependent kinase inhibitors and has well established roles in inhibiting cyclin-CDK 
complexes (Choudhury et al., 2007; Parker et al., 1995; Spencer et al., 2013) and 
satellite cell homeostasis (Carlson et al., 2008; George et al., 2013). qPCR analyses 
of freshly FACS sorted satellite cells revealed a dramatic up-regulation of p21 gene 
expression in PRMT5 deficient SCs indicating a transcriptional inhibition of p21 by 
PRMT5 in vivo (Figure 5.6.1A). Consistently, transcriptional profiling of satellite cells 
from Prmt5sKO mice, culture-amplified and subsequently treated with 4-hydroxy-
tamoxifen (4-OH) (Figure 5.6.1B), revealed a dramatic depletion of PRMT5 and up-
regulation of p21 (Figure 5.6.1C&D). In addtition, I observed a dramatic down-
regulation of the cell cycle regulator CyclinB1, a p21 target gene(Figure 5.6.1D). 
Figure 5.5 Genetic ablation of PRMT5 in differentiated myonuclei results in normal 
muscle regeneration upon acute muscle injury 
(A) Breeding scheme of Prmt5
fl/fl
 mice with HSA
CreERT2
 mice.  
(B) Representative images of TA muscles of wild type, HSA
CreERT2 
/Prmt5
fl/+ 
and HSA
CreERT2 
/Prmt5
fl/fl
 littermates (n=3) 14 days after CTX injection. 
(C) H&E staining of TA muscles from wild type, HSA
CreERT2 
/Prmt5
fl/+ 
and HSA
CreERT2 
/Prmt5
fl/fl
 
littermates (n=3) 14 days after CTX injection. Scale bar indicates 50 μm. 
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Interestingly, transcription of myogenic factors including Pax7, MyoD and Myf5 was 
not affected in PRMT5 deficient SCs suggesting that PRMT5 does not directly 
influence transcription of these genes (Figure 5.6.1D).  
 
 
5.6.2 Identification of cis-regulatory elements in p21 gene locus 
To determine whether PRMT5 directly binds the p21 locus thereby suppressing its 
expression, I carried out chromatin immunoprecipitation (ChIP) experiments in 
isolated control and PRMT5 deficient satellite cells. First, I did a comprehensively 
survey of cis-regulatory elements across the entire mouse p21 gene by analyzing 
published ChIP-seq results in various cell lines using GEO browser in order to 
Figure 5.6.1 cell cycle inhibitor p21 gene is identified as a downstream target of PRMT5 
by RNA-seq assay 
(A) RT-qPCR analysis showing an up-regulation of p21 expression in satellite cells isolated 
from Prmt5sKO mice. The expression level of mRNAs is normalized to mRNA of GAPDH. 
Error bars indicate the standard deviation (Paired t test: *P<0.05, n=3). 
(B) Experimental strategy showing ablation of PRMT5 upon 4-OH-tamoxifen administration in 
vitro. 
(C)Western blots showing depletion of PRMT5 protein in isolated satellite cells from Prmt5
sKO
 
as compared to control littermates after 4-OH tamoxifen administration in vitro. GAPDH is 
used as protein loading control. 
(D) RT-qPCR analysis of Prmt5, p21, CyclinB1 and myogenic factor expression in cultured 
satellite cells where PRMT5 ablation is induced upon 4-OH-tamoxifen administration. The 
expression level of different mRNAs is normalized to mRNA of Gapdh. Error bars indicate 
the standard deviation (Paired t test: *P<0.05, **P<0.01, n=3). 
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identify potential transcription factor binding sites (TFBS) and chromatin modification 
profiles, which is not known in mouse p21 locus so far.  
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  I examined RNA polymerase II (Pol II), H3K4me3 and H3K4me1 in mouse cell lines 
and H3K27ac in human cell lines. While Pol II signals mark the transcription start site 
(TSS) of the active p21 transcription, H3K4me3 modification is enriched between 
TSS and 1.5kb downstream of TSS within the first intron. This region is also a GC-
rich region and is targeted by transcription factor Sp1/KLF family member promoting 
p21 expression in human cells (Siatecka et al., 2010) (Figure 5.6.2A). Phylogenetic 
alignment of evolutionarily conserved transcription factor binding sites within p21 loci 
from mouse and human revealed a consensus E2F1 and CREB binding sites 
embeded in this region (Figure 5.6.2C). Furthermore, both H3K4me1 (mouse cell 
lines) and H3K27ac (human cell lines) are peaked at around 10kb upstream of TSS 
indicating a potential enhancer region (Figure 5.6.2A&B), which was confirmed by 
ChIP using antibodies against H3K4me1 and H3K27ac in mouse ES cells (Figure 
5.6.2D). In addition, I found a conserved p53 consensus motif at the proximal 
promoter that is enriched with both H3K4me1 and H3K27me3 (Figure 5.6.2C). In 
aggregate, four cis-regulatory regions in murine p21 locus: up-stream enhancer 
region (-10kb,En), p53 binding site (-2kb, p53BS), transcription start site (+10bp,TSS) 
and down-stream intronic CpG island (+700bp, CpG) were identified by 
bioinformatics and experimental analyses (Figure 5.6.2E). 
5.6.3 PRMT5 mediated H3R8me2s at the p53BS of p21 gene 
Next I examined the association of PRMT5 and distinct histone modifications with 
these four regulatory regions in the murine p21 gene locus in control and PRMT5 
deficient satellite cells by ChIP analysis. PRMT5 was highly enriched at the En and 
p53BS loci but not at the TSS and CpG loci in control SCs. Tamoxifen administration 
led to loss of PRMT5 association to the En and p53BS loci (Figure 5.6.3A). 
Figure 5.6.2 Important regulatory regions within murine p21 locus 
(A) NCBI genome browser indicating the potential enhancer, promoter and transcription start 
site of murine p21 locus by analyzing published ChIP-seq results of H3K4me1, H3K4me3 
and Pol II in different murine cell lines. 
(B) NCBI genome browser indicating the enhancer region of p21 by analyzing published 
ChIP-seq results of enhancer marker H3K27ac in different human cell lines. 
(C) Evolutionary conserved region analysis by ECR browser identified p53, CREB and E2F1 
binding sites. 
(D) ChIP-PCR of H3K4me1 and H3K27ac at p21 locus in murine ES cells showing a 10kb 
region upstream of p21 transcription start site as an enhancer like region. 
(E)  Schematic of four regulatory regions: enhancer like (En), p53 binding site (p53BS), 
transcription start site (TSS), and intronic CpG island (CpG) within murine p21 locus 
identified by bioinformatics analyzing the published ChIP-seq data. 
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Consequently, significant reduction of histone H3 arginine 8 symmetric dimethylation 
(H3R8me2s), an enzymatic product of PRMT5 (Bedford and Richard, 2005), was 
found at the p53BS locus (Figure 5.6.2B). Consistent with transcriptional activation of 
p21 upon PRMT5 ablation, a significant loss of nucleosome occupancy was detected 
at the TSS locus as monitored by histone H3 ChIP (Figure 5.6.2C). In addition, an 
increase of the euchromatic histone mark H3K4me3 was detected in PRMT5 
deficient satellite cells at the CpG locus, indicating that PRMT5 mediated H3R8 
symmetric dimethylation induced heterochromatin formation at the p53BS resulting in 
p21 gene suppression (Figure 5.6.2D).  
 
 
 
5.6.4 Up-regulation of p21 upon PRMT5 deletion is p53-independent  
p53-dependent and independent activation of p21 gene expression has been 
described during cell growth and differentiation and upon DNA damage (Macleod et 
al., 1995; Parker et al., 1995). My transcription analysis of p21 gene expression in 
p53 and PRMT5 double knockout (p53-/-/Prmt5sKO) satellite cells revealed an up-
Figure 5.6.3 Ablation of PRMT5 in satellite cells results in loss of H3R8me2s at p53 
binding site and formation of euchromatic structure at TSS and CpG island within 
murine p21 locus  
(A) , (B), (C)&(D) ChIP-qPCR analysis of Prmt5 (A), H3R8me2s (B), histone H3 (C) and 
H3K4me3 (D) at four regulatory regions (enhancer-like, p53 binding site, TSS and intronic 
CpG island) within p21 gene locus in satellite cells isolated from Prmt5
sKO
 mice and control 
littermates. The relative enrichment of Prmt5 and H3 is normalized against the input DNA 
and the enrichment of H3R8me2 and H3K4me3 is normalized to histone H3. Error bars 
represent standard deviations of the mean (t test: **p < 0.01, *p < 0.05, ns p>0.05).  
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regulation of p21 compared to control cells indicating that p21 up-regulation in 
satellite cells upon PRMT5 ablation occurs independently of p53 (Figure 5.6.4E). 
 
 
 
5.6.5 p21 deletion partially restores the proliferative capacity of Prmt5sKO 
SCs  
To further address whether p21 is the main downstream factor that mediates 
impaired cellular functions of SCs upon PRMT5 ablation, I generated double mutant 
mice by crossing Prmt5sKO mice to p21 null mice (Deng et al., 1995). The resulting 
Prmt5sKO/p21-/- mice allowed me to analyze whether the inhibition of proliferation of 
PRMT5 deficient SCs is rescued in a p21 null background. A pure population of  
Figure 5.6.4 Ablation of PRMT5 activates p21 gene expression in a p53 independent 
manner 
(A) ChIP-qPCR assay showing a reduction of p53 binding to p21 locus in PRMT5 deficient 
satellite cells. The relative enrichment of p53 is normalized against the input DNA. Error 
bars represent standard deviations of the mean (t test: **p < 0.01, n=3).   
(B) Western blot showing the protein level of p53 in satellite cells from Prmt5
sKO
 mice and 
control littermates (n=2) after 4-OH tamoxifen administration in vitro. 
(C) RT-qPCR showing the relative transcription of p53 gene in satellite cells from Prmt5
sKO 
mice as compared to control littermates. Error bars represent standard deviations of the 
mean (t test: ns p>0.05, n=3). 
(D) Semi-quantitative RT-PCR showing the Mdm4 full-length transcripts (Mdm4fl) and splicing 
variant (Mdm4s) in satellite cells from Prmt5
sKO
 mice and control littermates. The 
transcripts of Mdm4 using primers in 3’UTR detecting both Mdm4f and Mdm4s and 
transcripts of m36B4 are shown below as RNA loading control. 
(E) RT-qPCR showing the relative transcription of Prmt5, p53 and p21 gene in satellite cells 
from Prmt5
sKO 
mice as compared to control littermates. Error bars represent standard 
deviations of the mean (t test: *p<0.5; **p<0.01, n=3). 
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satellite cells was isolated by FACS sorting using negative cell surface markers 
CD11b, CD45 and CD31 that exclude leucocytes and endothelial cells, and positive 
Figure 5.6.5 Genetic ablation of p21 gene partially restores the proliferation capability 
of PRMT5 deficient satellite cells 
(A)EdU incorporation assay in isolated SCs from single and double knockout mice revealing 
a partial but significant recovery of SC proliferation from Prmt5
sKO
/p21
-/-
 mice (n=3) as 
compared to Prmt5
sKO
 mice (n=3). Quantification of EdU positive cells is shown. Error bars 
represent standard deviations of the mean (t-test: **p < 0.01). Scale bar indicates 200 μm. 
(B)Immunofluorescence assay of Pax7 positive colonies in isolated myofibers cultured for 3 
days showing an increased number of proliferating Pax7+ colonies in Prmt5
sKO
/p21
-/-
 mice 
(n=4) as compared with Prmt5
sKO
 mice (n=4). Pax7 positive colonies from 100 myofibers 
are counted. Quantification of Pax7 positive colony is shown. Error bars represent 
standard deviations of the mean (t-test: **p < 0.01). Scale bar indicates 100 μm. 
(C)Schematic of muscle regeneration assay upon acute muscle injury in control and Prmt5
sKO 
littermates (n=3) upon tamoxifen administration for 3 weeks. TA muscle injury was 
induced by cardiotoxin (CTX) injection 5 days after initial tamoxifen injection and muscle 
regeneration was analyzed 2 weeks later. 
(D)Representative images of TA muscles of from single and double knockout littermates 
(n=3) 14 days after CTX injection. 
(E)H&E staining of TA muscles from single and double knockout littermates (n=3) 14 days 
after CTX injection. Scale bar indicates 50 μm. 
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markers alpha integrin and CD34 that label the satellite cells. In vitro EdU 
incorporation assay in SCs isolated from single and double knockout mice revealed a 
partial but significant restoration of SC proliferation in Prmt5sKO/p21-/- mice compared 
to Prmt5sKO mice (Figure 5.6.5 A). Consistently, ex vivo clone numbers on isolated 
myotubes cultured for 3 days increased significantly in double knockout mice as 
compared with Prmt5sKO mice as well (Figure 5.6.5 B). However, satellite cell 
mediated muscle regeneration upon CTX injection was still impaired in Prmt5sKO/p21-
/- similar to Prmt5sKO mice (Figure 5.6.5 C,D&E). These data indicate that epigenetic 
regulation of the p21 gene locus by PRMT5 directly controls satellite cell proliferation 
during satellite cell expansion, and additional PRMT5 targets in SCs might be 
required for mediating PRMT5 function during later phases of muscle regeneration. 
5.7 PRMT5 is dispensable for embryonic and fetal muscle 
development and Pax7 expressing muscle progenitor 
expansion 
Muscle progenitors and satellite cells use similar regulatory molecules during 
developmental myogenesis and regenerative myogenesis respectively (Kang and 
Krauss, 2010). Hence, I reasoned that PRMT5 might not only control satellite cell 
proliferation and muscle regeneration but might also play a role in expanding muscle 
precursors and formation of skeletal muscle tissue during development. To test this I 
used a Pax7Cre knock-in mouse strain (Pax7Cre) that enables deletion of PRMT5 in 
Pax7 expressing cells during development (Keller et al., 2004) (Figure 5.7A). I 
isolated wild type and Pax7Cre/Prmt5loxP/loxP (hereafter referred to as conditional 
muscle specific PRMT5 knockout, Prmt5mKO; Pax7Cre/Prmt5loxP/+ as control (Ctrl)) 
mutant embryos at distinct embryonic days E9.5, E12.5 and E16.5. Surprisingly, 
embryos lacking PRMT5 in the Pax7 lineage were indistinguishable from wild type 
embryos isolated from the same pregnant mother mice at all indicated time points 
(Figure 5.7B). Detailed analyses on cross-sections of embryonic muscle from fore 
limbs of E12.5 and E14.5 embryos revealed indistinguishable immunofluorescent 
detection of Pax7+, MyoG+ and MF20+ cells in control and Prmt5mKO embryos 
(Figure 5.7C&D), demonstrating that PRMT5 is dispensable for Pax7+ myogenic 
precursor cell expansion and muscle differentiation during early embryonic muscle 
development similarly. At E16.5, a later time-point when Pax7+ muscle progenitor 
cells already play an important role in fetal muscle growth (Hutcheson et al., 2009), 
inactivation of PRMT5 in muscle progenitors had no obvious effect on Pax7+, MyoD+  
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Figure 5.7 PRMT5 is dispensable for embryonic Pax7+ muscle progenitor cell 
proliferation and differentiation 
(A) Breeding scheme of Prmt5
loxp/loxp
 mice with Pax7
ICN
 mice. 
(B) Representative images of control and Prmt5
mKO
 embryos at embryonic day E12.5, E14.5 
and E16.5. Scale bar indicates 10 mm. 
(C) Representative immunofluorescence images of cryo-sections of forelimb (E12.5 Frontal, 
upper panel; E14.5 Saggital low panel) showing expression of Pax7 (green) and Myogenin 
(red). DNA is stained with DAPI (blue). Scale bar indicates 200 μm. 
(D) Representative immunofluorescence images of cryo-sections of forelimb (E12.5 Frontal, 
upper panel; E14.5 Saggital low panel) showing expression of MF20 (green). DNA is 
stained with DAPI (blue). Scale bar indicates 200 μm. 
(E) &(F) Representative immunofluorescence images of cryo-sections of hindlimb (E16.5 
Transverse, upper panel) and forelimb (E16.5 Frontal, low panel) showing expression of 
Pax7 (green) and Myogenin (red) in (E), and Pax7 (green) and MyoD (red) in (F). DNA is 
stained with DAPI (blue). Scale bar indicates 200 μm. For the inserts scale bar indicates 
20 μm. 
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and MyoG+ expression in both fore and hind limbs as well indicating that myogenic 
cell proliferation and differentiation was not affected and muscle development was 
normal (Figure 5.7E&F). These results demonstrated that PRMT5 is dispensable for 
Pax7+ myogenic precursor cell expansion during embryonic and fetal muscle 
development, highlighting a distinct genetic requirement for PRMT5 in regulating 
muscle progenitor cell expansion and satellite cell proliferation.  
5.8 The role of PRMT5 in high order chromatin organization of 
satellite cells  
Quiescent satellite cells differ from fully differentiated myocytes is repect to the 
organization of heterochromatin indicating that control of high order heterochromatin 
organization is causally involved in the regulation of muscle stem cell homeostasis 
(Shi and Garry, 2006). Consistently, loss of Pax7 leads to loss of heterochromatic 
structure within nucleus of satellite cells and impairment of muscle regeneration 
(Gunther et al., 2013). The high enrichment of PRMT5 in nucleus of satellite cells 
prompted me to investigate whether PRMT5 controls high order chromatin structure.  
 
 
The high order heterochromatin structure was monitored by immunofluorescence 
assay using antibodies against heterochromatic histone modification marks such as 
H3K27me3 and H4K20me2 in freshly isolated myofibers. The enrichment of 
H3K27me3 and H4K20me2 within nuclei of satellite cells did not change in Prmt5sKO 
Figure 5.8 Global alterations of histone modifications in satellite cells lacking PRMT5  
(A)Immunofluorescence analyses showing no alteration of H4K20me2 and H3K27me3 in 
satellite cells on freshly isolated myofibers from control and Prmt5
sKO
 mice.   
(B)Western blot showing the changes of histone modifications in satellite cells from Prmt5
sKO
 
mice and control littermates (n=2) after 4-OH tamoxifen administration in vitro. Histone H3 
is used as a histone loading control. 
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mutant compared to control mice, suggesting an intact chromatin structure in PRMT5 
deficient satellite cells (Figure 5.9A).  
  Furthermore, western blot assay of histone modifications using in vitro 4-OH-
tamoxifen treated Prmt5sKO satellite cells and control cells revealed no alteration of 
H3K27me3 and H4K20me2 in both control and PRMT5 deficient satellite cells 
(Figure 5.9B). Surprisingly, I detected a dramatic reduction of H4K20me1 in PRMT5 
deficient cells (Figure 5.9B). This might be due to a strong cell cycle block given that 
H4K20me1 has been linked to cell cycle regulation(Beck et al., 2012b). Further 
detailed analyses of chromatin structure of satellite cells from wild type and PRMT5 
deficient mice using MNase digestion and electron microscopy will help to 
understand the role of PRMT5 in chromatin structure control. 
5.9 Genome wide epigenetic profiling of H4K20me1 and its 
correlation with active transcription. 
The enrichment of H4K20me2 within SCs prompted me to identify genes that are 
labeled by H4K20me2 together with H4K20me1 and H4K20me3 using chromatin 
immunoprecipitation coupled to high-throughput sequencing (ChIP-seq). I used 
proliferating as well as differentiating C2C12 cell, a myogenic cell line derived from 
satellite cells. For each sequencing sample, 10ng ChIPed DNA was collected and 
subjected to Illumina HiSeq. Around 20 million reads were obtained for each sample. 
5.9.1 H4K20me1 is enriched within gene body. 
After read mapping to the genome and peak calling, high enrichment of H4K20me1 
on gene bodies especially in differentiated C2C12 cells was observed whereas no 
significant the peaks for H4K20me2 and H4K20me3 were identified in both 
proliferating and differentiating C2C12 cells. Therefore I focused my further 
experiments and the analyses on H4K20me1. The ChIP-seq data were confirmed by 
ChIP-qPCR on randomly picked single gene Med2d (5.10.1A&B). Bioinformatics 
analysis of the H4K20me1 peak distribution revealed that H4K20me1 are more 
enriched in the intronic and exonic regions and are strongly depleted in intergenic 
regions in differentiated C2C12 cells in comparison with the distribution in 
proliferating cells as well as genomic control annotations (“all”), (5.10.1C).  This 
indicates that H4K20me1 is more enriched within gene bodies especially in 
differentiated cells. Next, the gene-body regions were binned into 50 bins of variable 
size (corresponding to gene size) and clustered using hierarchical k-means. Heat 
map showed that Cluster I that is highly enriched of H4K20me1 contains around 420 
genes and shows a strong binding within the gene body (5.10.1D). Gene ontology 
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analysis of cluster I genes revealed a population of highly expressed housekeeping 
genes indicating that H4K20me1 correlates with transcription activation. 
 
 
5.9.2 H4K20me1 correlates with RNA polymerase II and gene 
transcription level 
To further validate my results, I carried out bioinformatics analysis on the correlation 
of H4K20me1 with published ChIP-seq data of several known molecular markers that 
indicate active transcription in C2C12 cells (Asp et al., 2011). Consistently I detected 
a strong correlation between H4K20me1 and Pol II in differentiating C2C12 cells 
while the correlation in proliferating cells was weaker (Figure 5.10.2A). Moreover, 
average binding (number of reads per body/gene length) was calculated and used as 
a measurement to bin the set of mouse genes into 10 equal-size bins sorted for 
binding. Average binding was increased from bin 1 to 10. When plotting bins against 
gene expression values determined from GEO entry GSE11415, I observed an 
increased level of average gene expression which followed the increased H4K20me1 
Figure 5.9.1 Genomic distribution of H4K20me1 in proliferating and differentiating 
C2C12 cells 
(A) Representative example of ChIP-Seq enrichment peaks for H4K20me1 at Mef2d gene. 
(B) Confirmation of H4K20me1 association at Med2d gene by ChIP-qPCR.  
(C) Basic distribution analysis of H4K20me1 ChIP-seq results showing an increased 
association of H4K20me1 within exons and introns. 
(D) Heat map profile showing high enrichment of H4K20me1 within the gene body in 
differentiating C2C12 cells. Each row of the heatmap represents the binding pattern of 
H4K20me1 across the −5 kb to +5 kb region flanking the TSS and TES. Gene body region 
was binned into 50 bins of variable size (corresponding to gene size) and clustered using 
hierarchical k-means. 
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enrichment, indicating gene expression is positively associated with the H4K20me1 
bound nucleosomes (Figure 5.10.2B).    
 
 
 
  Then I analyzed promoter characteristics of H4K20me1 bound genes. It has been 
shown that high CpG density correlates with active gene transcription (Deaton and 
Bird, 2011). To address whether H4K20me1 associated with genes that show a high 
CpG density, I separated the gene promoters into 10 classes according to the CpG 
density (from 10 =highest density to 1=lowest density) and plotted the average 
H4K20me1 binding to different promoter classes. Notably, the nucleosomes in 
promoter with higher CpG density were always decorated with more H4K20me1 
(Figure 5.10.2C), indicating H4K20me1 is involved in transcriptional regulation of 
CpG-rich promoters.   
Figure 5.9.2 H4K20me1 association correlates 
with active transcription. 
(A)Average binding (number of reads per 
body/gene length) of H4K20me1 plotted 
against gene expression values in 
differentiating cells showing a nice correlation 
between H4K20me1 binding over gene bodies 
with gene expression level. 
(B)Heat map profile showing high correlation 
between H4K20me1 association and Pol II 
binding in differentiating cells. 
(C) H4K20me1 is associated with high CpG promoter in differentiating cells. Average binding 
(number of reads per body/gene length) of H4K20me1 in differentiating cells was plotted 
against the CpG density rank of each promoter. Gene body data is plotted as 60 bins 
spanning the whole gene body of 27000 mouse ref-seq genes. For each promoter the CpG 
density was calculated and 10 promoter classes were assigned based on the CpG density 
rank (from 10 = highest density to 1=lowest density). 
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5.9.3 H4K20me1 and H3K36me3 show different distribution within the 
gene body. 
To further understand how H4K20me1 is involved in active gene transcription, I 
examined the average normalized tag densities across all genes or subsets of genes 
according to their respective expression levels. H4K20me1 distribution within the 
gene body showed a peak close to the promoter at the transcription start site with a 
decreased association at the end of the genes. This pattern is different from the 
distribution of another histone modification H3K36me3, which has been shown to 
positively correlate with gene activation and is enriched in gene bodiesl. H3K36me3 
peaked later at the transcription end site (TES) (5.10.3 A&B). Consistently Set2 in 
yeast (homolog HYPB in human), the epigenetic modifier catalyzing H3K36me3, is 
capable of binding directly to RNA polymerase II with COOH-terminal domain (CTD) 
phosphorylated on Ser2 (Ser2P) that is highly enriched in TES (Hossain et al., 2013). 
These findings indicated that H4K20me1 might be involved in the early stage of 
transcription elongation.  
 
 
Figure 5.9.3 Different distribution of H4K20me1 and H3K36me3 in coding region of 
activated genes. 
(A)&(B) The average ChIP enrichment signals from H4K20me1 (A) and H3K36me3 (B) in 
differentiating cells on the meta-gene of 3 kb. Average binding across subsets of genes 
ordered for their respective expression levels was plotted. Groups 1 to 4 are ordered for 
increasing expression level. The black color indicates all RefSeq genes. 
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5.10 The enrichment of H4K20me1 at the gene body is Pol II 
independent 
To address whether the enrichment of H4K20me1 at the gene body is dependent on 
early elongating Pol II that could be distinguished from late elongation Pol II by CTD 
phosphorylation at Ser5 (Ser5P), I treated proliferating and differentiating C2C12 
cells with three distinct transcription elongation inhibitors: α-Amanitin, Actinomycin D 
and DRB. While α-Amanitin binds to Pol II and blocks the incorporation of new 
ribonucleotides into the nascent RNA chains (de Mercoyrol et al., 1989), Actinomycin 
D intercalates into DNA thereby preventing the progression of RNA polymerases 
(Casse et al., 1999). DRB, a protein kinase inhibitor, blocks the CTD phosphorylation 
therefore impairs transcription initiation and elongation (Yamaguchi et al., 1999).  
 
 
Treatment of the cells for 3 hours with DRB led to a significant reduction of CTD 
phosphorylation and H3K36me3 in differentiated C2C12 cell, consistent with role of 
Set2 mediated H3K36me3 depending on elongating Pol II (Figure 5.11A). 
Interestingly neither H4K20me1 in histones nor its incorporation within the gene 
bodies of targeted gene such as Cdc20 and Myogenin changed upon DRB treatment 
Figure 5.10 The enrichment of H4K20me1 at the gene body is independent on 
elongating Pol II 
(A) Western blot using DRB treated proliferating and differentiating C2C12 cells showing that 
DRB inhibits Ser5 and Ser2 phosphorylation of Pol II without affecting the level of PR-Set7 
and H4K20me1. 
(B) &(C) ChIP-qPCR analysis showing unchanged level of H4K20me1 within the gene body in 
DRB treated and untreated C2C12 cells in both proliferating and differentiating stage. 
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as compared to untreated cells (Figure 5.11B&C). These findings suggested that 
H4K20me1 incorporation within the coding region during transcription elongation is 
Pol II independent. 
 
 
5.12 PR-Set7 mediated H4K20me1 is required for the 
transcription of Cdc20 
Figure 5.11 PR-Set7 and H4K20me1 are required for Cdc20 gene transcription  
(A)ChIP-qPCR of H4K20me1 at three regulatory regions (-200bp, +400bp and +2kb) within 
Cdc20 locus in proliferating and differentiating C2C12 cells. The relative enrichment of 
H4K20me1 is normalized to histone H3. Error bars represent standard deviations of the 
mean.  
(B)ChIP-qPCR of PR-Set7 binding to -200bp and +400bp of Cdc20 gene. ChIPs were 
performed using anti-HA antibodies in proliferating and differentiating stable C2C12 cell 
lines expressing HA-tagged PR-Set7. Error bars represent standard deviations of the 
mean (t test: **p < 0.01).  
(C)RT-qPCR analysis showing reduction of PR-Set7 expression in stable C2C12 cell lines 
transfected with two shRNAs targeting PR-Set7 as compared to scramble shRNA. Error 
bars represent standard deviations of the mean (t-test: **p < 0.01).  
(D)RT-qPCR analysis showing reduction of Cdc20 expression in stable C2C12 cell lines 
transfected with two shRNAs targeting PR-Set7 as compared to scramble RNA.  
(E)Western blot assay showing decreased H4K20me1 level in stable C2C12 cell lines 
transfected with two shRNAs targeting PR-Set7 as compared to scramble RNA. Histone 
H3 is used as a protein loading control. 
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PR-Set7/Set8/KMT5a has been shown to be the sole epigenetic modifying enzyme 
that catalyzes monomethylation of H4K20 (H4K20me1) (Schotta et al., 2008). To 
address whether PR-Set7 is associated with gene activation, chromatin IP using 
antibody against HA tag in C2C12 cells ectopically expressing PR-Set7-HA was 
carried out.  PR-Set7 only bound to the gene body of Cdc20 gene in the proliferating 
but not differentiating cells (Figure 5.12A), which is consistent with the enrichment 
pattern of H4K20me1 (Figure 5.12B). This suggested that PR-Set7 positively 
correlates with gene transcription. Furthermore I performed PR-Set7 loss of function 
assays using two short hairpin RNAs (shRNAs) targeting murine Pr-set7 in C2C12 
cells. PR-Set7 mRNA was significantly reduced as showed by RT-qPCR (Figure 
5.12C). Consequently the level of H4K20me1 decreased as well (Figure 5.12D). 
Consistent with the role of PR-Set7 in transcription activation, the mRNA of targeted 
gene Cdc20 was strongly decreased (Figure 5.12E). Taken together these results 
indicated that PR-Set7 mediated H4K20me1 is required for transcription activation, a 
finding that is in contrast to a previous study claiming a role of PR-Set7 and 
H4K20me1 in transcription silencing (Congdon et al., 2010).  
5.13 SILAC assay reveals interaction between PR-Set7 and 
multiple mRNA splicing factors  
To start to elucidate the molecular mechanisms underlying PR-Set7/H4K20me1 
mediated transcription activation, I identified PR-Set7 interaction partners within 
chromatin bound fractions using stable isotope labeling of amino acids in cell culture 
(SILAC)(Figure 5.13A). SILAC is the most commonly used method for metabolic 
labeling and depends on the incorporation of heavy isotope variants of arginine and 
lysine which, combined with tryptic protein digestion, ensures the labeling of all 
peptides except the very C-terminal ones. Compared to the “light” peptide, 
incorporation of “heavy” amino acids results in a defined mass shift that is detectable 
in MS survey scans. In brief, C2C12 cells that are ectopically expressing PR-Set7-HA 
were grown in heavy medium (Arg8, Lys10), while C2C12 cells with empty vector 
were labeled with nature arginine and lysine (light, Arg0, Lys0). Affinity purification of 
the HA-tagged PR-Set7 was then performed separately and immunoprecipitates 
were mixed before MS analysis from both cell lysates within proliferating and 
differentiating conditions (Figure 5.13A). In total, I identified 17 proteins that interact 
with PR-Set7 in proliferating and differentiating C2C12 cells. Interestingly among the 
PR-Set7 interaction partners several mRNA splicing factors such as Srrm2, 
Hnrnpa2b1, Prp8, Dnajc13 and Caper were identified. This suggested that PR-Set7 
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and H4K20me1 might be involved in co-transcription splicing thereby regulating 
transcriptional elongation during active gene expression. Further studies will focus on 
this hypothesis to elucidate the transcriptional role of PR-Set7/H4K20me1. 
 
 
Figure 5.12 mRNA splicing factors are identified as PR-Set7 interaction partners by 
SILAC assay. 
(A) Strategy of double-label SILAC experiment to identify the interaction partners of PR-Set7 
in proliferating and differentiating C2C12 cells stably expressing HA-tagged PR-Set7.  
(B) Scatter plot representing the proteins immunopurified together with PR-Set7 in 
proliferating and differentiating stable C2C12 cell lines. The summed peptide intensity 
distribution was plotted against the corresponding protein fold change (SILAC ratio) 
following immunoprecipitation.  
(C) Table listing mRNA splicing factors that are identified as potential interaction partners of 
PR-Set7 by SILAC assay with the log2 SILAC ratio.  
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6 DISCUSSION 
Adult muscle stem cells, also known as satellite cells, originate from muscle 
precursors during embryonic development and are required for adult muscle 
regeneration. Loss of satellite cells and deregulation of satellite cell homeostasis 
leads to deficient muscle repair under physiological conditions, during aging and 
pathological conditions such as muscular dystrophy. Here, I found that the protein 
arginine methyltransferase 5 (PRMT5) is highly enriched in satellite cells. Loss of 
PRMT5 in satellite cells of adult mice not only leads to a massive decline of the 
number of muscle stem cells during aging, but also completely abolishes muscle 
regeneration in both physiological and pathological conditions in vivo. Furthermore, I 
showed that PRMT5 is required for the proliferation of Pax7+/MyoD+ cells and 
formation of differentiated myogenic cells (Pax7-/MyoG+) but not for myofiber 
maturation (MyHC+). At the molecular level, PRMT5 directly modulates chromatin 
structure thereby epigenetic silencing the cell cycle inhibitor p21 gene locus. Loss of 
p21 can partially restore the proliferation defects of PRMT5 deficient satellite cells. 
Interestingly, inactivation of PRMT5 in Pax7 positive precursors does neither inhibit 
cell expansion nor myotome formation during muscle development. Taken together 
these findings demonstrate the distinct genetic and epigenetic requirements of 
PRMT5 for Pax7+ muscle progenitor proliferation during muscle development and 
satellite cell proliferation during adult muscle regeneration (Figure 6). 
 
 
 
 
Figure 6 Model depicting distinct genetic requirement for PRMT5 in control of fetal 
myogenesis and regenerative myogenesis. 
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6.1 PRMT5 dependent mechanism of satellite cell proliferation  
Previous studies have revealed an important function of PRMT5 for ES cell 
proliferation in vitro and neural progenitor cell proliferation during brain development, 
suggesting a general role of PRMT5 in cell proliferation control in different tissues 
and cell types (Bezzi et al., 2013; Gkountela et al., 2014; Tee et al., 2010). However, 
the function of PRMT5 in regulating proliferation is context dependent. A cellular 
feature that might confer different PRMT5 functions in a cell type specific manner is 
chromatin structure. For example, compared to the loose and open euchromatin 
structure found in undifferentiated ES cells (Meshorer and Misteli, 2006), quiescent 
satellite cells contain highly compacted and condensed heterochromatin (Gunther et 
al., 2013; Shi and Garry, 2006; Zhou et al., 2011). We could show that PRMT5 is 
highly enriched in the nucleus of satellite cells and suppresses p21 gene transcription 
by heterochromatin organization thereby regulating satellite cell proliferation. 
Interestingly, in ES cells cytoplasmic PRMT5 plays an important role in regulating ES 
cell pluripotency by modulating the cytoplasmic LIF/Stat3 signaling pathway and 
indirectly suppressing genes that are associated with ES cell differentiation(Tee et al., 
2010). Therefore, it seems that cytoplasmic or nuclear localization of PRMT5 could 
be involved in regulating proliferation in alternative ways in conjunction with distinct 
chromatin organizations in different cell types (Gu et al., 2012). Furthermore, nuclear 
PRMT5 appears to apply yet again distinct mechanisms to regulate neural progenitor 
and muscle stem cell proliferation. PRMT5 has been shown to regulate proliferation 
of NSCs by mediating alternative splicing events of Mdm4 that in turn leads to p53 
stabilization, up-regulation of p21 and cell cycle progression. Consistently, ablation of 
p53 partially rescues the proliferation defects of PRMT5 deficient NPCs in vitro and in 
vivo (Bezzi et al., 2013). However, in proliferating satellite cells, the up-regulation of 
p21 gene expression upon PRMT5 ablation appears to be p53 independent since the 
binding of p53 to the p21 locus is diminished with the absence of H3R8me2s and 
PRMT5 (Figure 5.6.4A). Furthermore, p53 expression in PRMT5 deficient SCs is not 
altered, both at the mRNA and protein level, even though alternative splicing  of 
Mdm4 occur (Figure 5.6.4B,C and D). Additionally an increased p21 level is still 
observed in p53 and PRMT5 double deficient satellite cells as compared to the 
control cells (Figure 5.6.4E). In muscle stem cells, I could show that PRMT5 is 
required to reorganize chromatin structure of the p21 gene locus and to silence p21 
gene expression. It is still an open question which transcription factors responsible 
for promoting transcription of the p21 gene in PRMT5 deficient satellite cells. One of 
the candidates is the muscle specific transcription factor MyoD, which has been 
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shown to activate p21 gene expression in cooperation with the transcriptional co-
activator p300 in cultured myoblasts (de la Serna et al., 2006; Puri et al., 1997a; Puri 
et al., 1997b). Others might be Sp1/KLF, CREB and E2F1, which bind to the CpG 
island within the first intron of p21 and activate p21 transcription in cancer cells lines 
in the p53-independent way (Siatecka et al., 2010). Therefore, it will be interesting to 
test whether binding of these transcription factors to the p21 locus are increased in 
satellite cells or muscle progenitors upon PRMT5 inactivation. Given that p21 is not 
the only downstream target that mediates PRMT5 function in satellite cell 
proliferation, systematic RNA-seq and ChIP-seq assays are necessary for a 
comprehensive understanding of the PRMT5 dependent mechanism of satellite cell 
proliferation. 
6.2 PRMT5 is required for satellite cell differentiation and 
muscle regeneration 
While PRMT5 dependent control of proliferation in different stem cells is context 
dependent, an additional function of PRMT5 apparently exists in muscle stem cell 
differentiation. In vivo lineage tracing experiments using a Rosa26YFP reporter 
revealed that satellite cells without PRMT5 are unable to form MyoG+ cells on 
myofibers. This could not be attributed to a secondary effect of an earlier event 
disrupting satellite cell proliferation, since acute in vitro ablation of PRMT5 in 
proliferating SCs already expressing MyoD, also abolished terminal differentiation 
and inhibited formation of MyoG and MF20 positive cells. Interestingly this finding is 
consistent with previous in vitro studies showing that PRMT5 is required for 
differentiation of C2C12 myoblasts (Dacwag et al., 2009; Dacwag et al., 2007). 
Moreover the requirement of PRMT5 in satellite cell differentiation during 
regeneration is restricted to the myoblast stage, since the HSACreERT2/Prmt5loxp/loxp 
mice that allow ablation of PRMT5 in fully differentiated myocytes show normal 
regenerative capability compared to the wild type. Furthermore, differentiation of 
satellite cells lacking PRMT5 triggers cell apoptosis in vitro, which might be a reason 
for the loss of satellite cell numbers after ablation of PRMT5 over a prolonged time 
and in a regenerative environment as well. These observations, together with the 
finding that p21 knockout could only partially rescue the proliferation defects but not 
the regeneration impairment in Prmt5sKO mice suggested that additional factors 
cooperate with or are targeted by PRMT5 at different stages of muscle regeneration 
(Figure 5.8). Conceivably, different cell types may express distinct recruitment factors 
or modulators of PRMT5, and PRMT5 may have distinct enzymatic substrates to 
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achieve cell type specific functions. To this end, cell type specific ChIP-seq 
experiments and the identification of cell type specific binding partners and 
substrates of PRMT5 will give more insight in elucidating the functions of PRMT5 in 
different contexts.  
6.3 Precise cell proliferation control by PRMT5 in muscle 
progenitors and adult muscle stem cells  
During development, myogenesis depends on highly proliferative muscle progenitor 
cells leading to pronounced increase of muscle mass. Similarly, regenerative 
myogenesis in adults relies on muscle stem cells to rebuild muscle mass after 
muscle injury. As such, regenerative myogenesis is reminiscent of developmental 
myogenesis under certain conditions (Parker et al., 2003). Along this line several 
factors and signaling pathways regulating muscle precursor cell expansion during 
development also play an important role in regulating satellite cell proliferation during 
regeneration. Prominent examples are the homeobox transcription factors Pax3 and 
the muscle regulatory factors (MRFs) such as MyoD, Myf5, MRF4 or MyoG, all of 
which follow similar sequential expression patterns and play similar roles during 
developmental and regenerative myogenesis (Braun and Gautel, 2011; Buckingham 
and Rigby, 2014; Le Grand and Rudnicki, 2007; Shi and Garry, 2006). However it 
has been suggested that distinct molecular processes distinguish cell proliferation 
between muscle precursors and adult muscle stem cells (Cornelison et al., 2004; 
Gunther et al., 2013; Lepper et al., 2009). Indeed, in this study I identified and 
characterized an essential role of the epigenetic modifier PRMT5 for muscle stem 
cell proliferation and muscle regeneration. Surprisingly, loss of Prmt5 does not affect 
Pax7+ muscle progenitor cell expansion and differentiation during muscle 
development.  
   One of the most obvious differences between developmental and regenerative 
myogenesis is the lack of quiescence of highly proliferative muscle progenitor cells 
during development, while satellite cells under non-regenerative physiological 
conditions are normally quiescent. During regeneration, and in contrast to muscle 
precursors, some activated satellite cells self-renew and return to quiescence to 
replenish the stem cell pool. This process has been attributed to asymmetric cell 
divisions of satellite cells, which might account for the functional differences of 
PRMT5 in muscle progenitors and satellite cells (Kuang et al., 2007). In the 
developing embryo rapidly dividing muscle precursors apparently do not receive 
signals from their microenvironment that would suffice for them to enter quiescence. 
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In contrast, it has been shown that signals emanating from the adult muscle stem cell 
niche play key roles in regulating stem cell asymmetry, fate and behavior 
(Chakkalakal et al., 2012). It is conceivable that PRMT5 mediated transcriptional and 
epigenetic control might be responsible for asymmetric division of satellite cells 
thereby differentially regulating adult stem cells and muscle progenitor cells 
(Bentzinger et al., 2013; Kuang et al., 2007; Yin et al., 2013a). Interestingly, a recent 
publication revealed that Prmt4, a protein arginine methyltransferase that is related to 
PRMT5 but catalyzes asymmetric but not symmetric arginine methylation in distinct 
histone residues, regulates asymmetric satellite cell division and muscle regeneration 
by methylating Pax7 directly and thereby influencing Pax7 mediated Myf5 gene 
expression (Kawabe et al., 2012). Whether Prmt4 would mediate epigenetic 
regulation of chromatin in satellite cell as an additional means to regulate asymmetric 
satellite cell division is still unknown. PRMT5 on the other hand appears not to 
control the transcription of myogenic factors such as Pax7 and Myf5 (Figure 5.6.1B), 
suggesting that PRMT5 might not directly control asymmetric division in satellite cells 
but rather controls proliferation in general by suppressing the cell cycle inhibitor p21. 
Notably, since adult muscle stem cells originate only from a minor fraction of 
Pax7+/MyoD+ muscle precursors during development (Kanisicak et al., 2009; Relaix 
et al., 2005; Schienda et al., 2006) (Seale et al., 2000), PRMT5 might not be 
responsible for the proliferation of the majority of Pax7+/MyoD+ progenitors but could 
instead mediate gene silencing in a subset of cells that will acquire quiescence and 
adult muscle stem cell features. Given that PRMT5 mediates p21 gene silencing in 
adult satellite cells together with the observation that PRMT5 expression decreases 
within the myotome as muscle development proceeds (Figure S5), it is tempting to 
propose that PRMT5 may gradually diminish its expression in differentiating muscle 
tissue during early embryonic development and label a minor fraction of muscle 
precursor cells that will give rise to Pax7+/MyoD-/p21- adult muscle stem cells. In 
support of this hypothesis, we did not detect PRMT5 in the differentiated myofibers 
and only in satellite cells and myoblasts. Further lineage tracing experiments of 
Pax7+/PRMT5+ double positive descendants during development will be necessary 
to answer this question. This hypothesis also raises the idea that PRMT5 might 
control reentry of adult quiescent satellite cells into the cell cycle. Quiescent satellite 
cells express low levels of p21 and high levels of Pax7 that is counterintuitive 
because Pax7 expression is required for self-renewal of actively proliferating satellite 
cells (Gunther et al., 2013; Oustanina et al., 2004). It is conceivable that PRMT5 
might regulate p21 expression levels as to retain satellite cells in a poised but 
quiescent state. Loss of PRMT5 results in up-regulation of p21 in satellite cells, and 
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this might increase the p21 dependent threshold that cannot be overcome for cell 
cycle reentry.         
   Recent studies have revealed distinct roles of Pax7 expressing progenitors during 
different time points along muscle development. While ablation of Pax7 expressing 
cells by Pax7iCre+;R26RDTA+ mice has little effect on embryonic myogenesis up to 
E14.5, there is a complete absence of fetal myogenic progenitors and myofibers 
upon depletion of Pax7 expressing cells from E14.5 to E18 (Hutcheson et al., 2009; 
Messina and Cossu, 2009). This finding together with the observations that Pax7 
expressing cells are required for regenerative myogenesis (Gunther et al., 2013; 
Lepper et al., 2009) indicates that Pax7 expressing myogenic cells are mainly 
required for fetal myogenesis and adult muscle regeneration. If PRMT5 were critical 
for controlling embryonic but not fetal muscle progenitor cell expansion during 
development, inactivation of PRMT5 in Pax7 expressing cells will not influence 
developmental myogenesis. Therefore, ablation of PRMT5 within Pax3 or Myf5 
lineages that are essential for early embryonic myogenesis will allow us to precisely 
delineate and narrow down the role of PRMT5 at different stages of muscle 
development. Along this line, comparative epigenetic, transcriptional and proteomic 
profiling of embryonic, fetal and adult Pax7 expressing cells will allow a more 
comprehensive understanding of the differences between developmental and 
regenerative myogenesis. Equally important will be to address how PRMT5 
expression itself is regulated in these two settings as well.  
6.4 Linking PRMT5 mediated satellite cell proliferation to 
Duchenne Muscular Dystrophy   
Human Duchenne Muscular Dystrophy (DMD) is a severe muscle wasting disease in 
which diaphragm and skeletal muscles are characterized by constant muscle 
degeneration/regeneration cycles. A recent study demonstrated that while DMD 
pathology is driven by dystrophin deficiency in myofibers, DMD is ultimately a stem 
cell exhaustion disease (Sacco et al., 2010). Indeed, myoblasts from DMD patients 
exhibit severe proliferative defects in vitro (Blau et al., 1983; Blau et al., 1985). 
Consistently, Sacco et al. reported that telomere shortening occurring in mdx mice 
completely lacking telomerase activity (mdx/mTR2G mice) resulted in muscle stem 
cell proliferation defects and the phenotype in these mice recapitulates the gross 
muscle defects seen in human DMD (Mourkioti et al., 2013; Sacco et al., 2010). 
Interestingly, the pathology was only obvious in 72 weeks old mdx/mTR2G mice. The 
pivotal role of PRMT5 in satellite cell mediated muscle regeneration is underscored 
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by the finding that loss of PRMT5 not only results in a dramatic loss of satellite cells 
over time but also in severe muscle wasting in mdx mice. Remarkably, the pathology 
in PRMT5sKO/mdx mice that is reminiscent of the dystrophic phenotype observed in 
DMD patients can be observed within only 90 days after induced deletion of PRMT5 
and specifically in satellite cells. While we are still lacking detailed physiological 
analyses of muscle function in Prmt5sKO/mdx mice, these findings provide an 
inducible and muscle stem cell specific genetic mouse model that enables to 
investigate early events during the onset and progression of DMD and might thus 
serve as a useful test system for therapeutic interventions.  
   It has not missed our attention that this model also fuels the debate on whether 
alternative stem cell types apart from Pax7+ SCs could contribute to muscle 
regeneration. As for mice lacking PRMT5 in Pax7 expressing satellite cells this does 
not seem to be the case. The finding that satellite cell specific deletion of PRMT5 
results in progressive loss of satellite cells over time both under physiological and 
pathological conditions, together with the observation that damaged muscle of 
Prmt5sKO mice could not be regenerated even 4 months after injury, indicates that 1) 
alternative stem cells to Pax7+ satellite cells cannot compensate for the regeneration 
impairment and satellite cell loss occurring in Prmt5sKO or Prmt5sKO/mdx mice, and 2) 
that Pax7+ cells are not sufficiently generated de novo if satellite cells are once lost 
given that Tamoxifen administration was applied only in the first 3 weeks. Intriguingly, 
it was recently shown that progressive loss of muscle stem cell numbers, activity and 
proliferation capacity during aging is associated with a high incidence of muscle stem 
cells that express elevated levels of p16 and p21, and this is due to elevated activity 
of the p38 mitogen-activated kinase pathway (Bernet et al., 2014; Cosgrove et al., 
2014; Sousa-Victor et al., 2014). Strikingly, in the study by Sousa-Victor et al., 
PRMT5 expression has been shown to be reduced in 12-month-old SAMP8 mice that 
serve as a mouse model of progeria (Sousa-Victor et al., 2014). These findings 
together with the fact that PRMT5 inactivation results in elevated p21 levels, impaired 
proliferation and loss of satellite cells over time gives rise to the notion that epigenetic 
deregulation of muscle stem cells due to loss of PRMT5 activity might partially 
contribute to the loss of satellite cell mediated regeneration during aging.  
6.5 PR-Set7, H4K20me1 and active transcription  
Histone H4 Lys 20 mono-methylation (H4K20me1) has been implicated in regulating 
diverse processes such as cell cycle progression, DNA replication, DNA repair and 
gene regulation. H4K20me1 is catalyzed by the sole enzyme termed PR-
Set7/Set8/KMT5 (Beck et al., 2012a; Schotta et al., 2008). Loss of  PR-Set7 
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diminishes not only H4k20me1 but also H4K20me2 and H4K20me3. Consequently 
mice lacking PR-Set7 show major defects of early embryonic development (Oda et 
al., 2009). Despite numerous efforts, the role of H4K20me1 and PR-Set7 in gene 
transcription remains elusive. While initial studies suggested a role of PR-Set7 
mediated H4K20me1 in transcriptional repression, recent epigenomic studies 
indicate a role of H4K20me1 in transcriptional activation (Abbas et al., 2010; Barski 
et al., 2007; Congdon et al., 2010; Wang et al., 2009). The released ChIP seq data 
from the human cell lines demonstrated that H4K20me1 is specifically enriched in 
intergenic regions and correlates with transcription activation. Along this line, ChIP-
seq data of H4K20me1 in both proliferating and differentiating C2C12 cells show a 
positive correlation of this modification with gene transcription activity, high CpG 
content promoters, Pol II binding and other active transcription modifications such as 
H3K4me3, H3K36me3. Depletion of Pr-set7 by shRNAs reduces H4K20me1 and 
targeted gene repression. Interestingly this correlation with active transcription is 
more obvious in differentiating cells as compared to proliferating cells. Given that PR-
Set7/H4K20me1 has been shown to actively regulate cell cycle and DNA replication, 
the less obvious correlation of ChIP-seq of H4K20me1 with transcription activation in 
proliferating cells might be due to the mixed mapping of H4K20me1 to sites of both 
DNA replication and gene transcription, which does not occur in differentiating cells 
with nearly no DNA replications. Furthermore transition from proliferating to 
differentiating C2C12 cells correlates with shifting of enrichment of H4K20me1 from 
the intergenic region to the intragenic region including TSS, introns and exons. 
Additional deep analyses of H4K20me1 ChIP-seq in differentiating C2C12 cells 
revealed that H4K20me1 predominantly peaks at the 5’ site of the gene body 
downstream from the TSS suggesting a role of H4K20me1 in early transcription 
elongation. This pattern of enrichment in the gene body is actually distinct from 
H3K36me3, whose enrichment peaks in the 3’ site near the transcription end site 
(TES) of the intron-containing genes. In yeast, it has been shown that the H3K36 
methyltransferase Set2 binds directly to Pol II CTD phosphorylated on Ser2 (Ser2P), 
which also peaks at the 3’ site of the gene body, linking Set2 mediated H3K36me3 to 
transcriptional elongation coupled mRNA splicing of intron-containing genes (de 
Almeida et al., 2011). It seems that PR-Set7 mediated H4K20me1 might use similar 
mechanism as Set2 mediated H3K36me3 in control of transcriptional elongation by 
associating with Pol II Ser5P CTD. Indeed recent studies by Paula Vertino and 
colleagues demonstrated a dual role of PR-Set7 and histone H4K20me1 in the local 
regulation of RNA Pol II pausing by establishing both the H4K16ac and H4K20me3 
marks (Kapoor-Vazirani and Vertino, 2014). Inhibition of the Ser5P CTD of Pol II by 
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DRB blocks transcription elongation but doesn’t affect the H4K20me1 enrichment 
within the gene body. Therefore, it is still worth to address how the crosstalk between 
PR-Set7 induced H4K20me1 and MSL mediated H4K16ac is required for Pol II 
Ser5P and relieve of transcription pausing. The association of H4K20me1 in the gene 
body also implies a role of PR-Set7/H4K20me1 in transcriptional coupled splicing as 
well. In support of this several splicing factors including Srrm2, Hnrnpa2b1, Prp8, 
Dnajc13 and Caperas have been identified as PR-Set7 interaction partners using Co-
IPand subsequent mass spectrometry. It will be very interesting to further analyze 
whether PR-Set7 and H4K20me1 are involved in co-transcriptional splicing thereby 
regulating transcriptional elongation during active gene expression in differentiating 
cells.  
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8 APPENDIX 
8.1 Abbreviations 
% Percent 
°C Degree Celsius 
A                  Adenine 
ATP Adenosine triphosphate 
BMP Bone morphogenetic protein 
bp Base pairs 
BSA Bovine serum albumin 
C                Cytosine 
CDK Cyclin-dependent kinase 
cDNA  Complementary DNA 
ChIP  Chromatin immunoprecipitation 
cm Centimeter 
CMV     Cytomegalovirus 
Co-IP  Co-immunopricipitation 
CpG  Cytosine-guanine dinucleotide 
CREB cAMP response element-binding protein 
CTX Cobra cardiotoxin 
CXCR-4 C-X-C chemokine receptor type 4 
DAPI 4',6-diamidino-2-phenylindole 
DMD Duchenne muscular dystrophy 
DMEM Dulbecco's Modified Eagle Medium 
DMSO Dimethyl sulfoxide 
DNA Deoxyribonucleic acid 
Dnajc13 DnaJ (Hsp40) homolog, subfamily C, member 13 
DNMT DNA methyltransferase 
DRB 5,6-dichloro-1-β-D-ribofuranosyl-1H-benzimidazole 
DTA Diphtheria toxin A 
DTT Dithiothreitol 
E. coli  Escherichia coli 
ECL Enhanced chemi-luminescence 
ECM Extracellular matrix 
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EDL Extensor digitorum longus 
EDTA Ethylenediaminetetraacetic acid 
EdU 5-ethynyl-2'-deoxyuridine 
ES Embryonic stem cell 
FAPs Fibro-adipogenic progenitors  
FCS Fetal calf serum 
FGF Fibroblast growth factor 
g Gram 
G   Guanine 
g       Gravitational acceleration 
GAPDH Glyceraldehyde 3-phosphate dehydrogenase 
GFP Green fluorescent protein 
h Hour 
H&E Hematoxylin and eosin 
H3K27me3 Histone H3 trimethyl Lysine 27 
H3K36me3 Histone H3 trimethyl Lysine 36 
H3K9me3 Histone H3 trimethyl Lysine 9 
H3R8me2s  Histone H3 symetrical dimethyl Arginine 8 
H4K20me1 Histone H4 monomethyl Lysine 20 
H4K20me2 Histone H4 dimethyl Lysine 20 
H4K20me3 Histone H4 trimethyl Lysine 20 
H4K4me3 Histone H4 trimethyl Lysine 4 
H4R3me2s Histone H4 symetrical dimethyl Arginine 3 
HA Hemagglutinin 
HBS HEPES Buffered Saline 
HDAC Histone deacetylases  
HE  Hematoxylin and eosin 
HEPES  4-(2-hydroxyethyl)-1-piperazineethanesulfonic acid 
Hnrnpa2b1 Heterogeneous Nuclear Ribonucleoprotein A2/B1 
HRP Horseradish peroxidase 
HSA Human skeletal actin 
IF Immunofluorescence 
IGF Insulin-like growth factor 
IgG Immunoglobulin G 
IP Immunoprecipitation  
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JNK c-Jun N-terminal kinases 
kb kilo-base pairs 
kDa kilodalton 
kg kilogram 
KO Knock Out 
M molar 
MEF2 Myocyte enhancer factor 2 
min Minute 
ml milliliter 
mm millimeter 
mM millimolar 
MNase Micrococcal Nuclease 
MPI Max-Planck Institute 
Mrf4 myogenic regulatory factor 4 
mRNA messenger RNA  
MS Mass spectrometry 
Myf5 Myogenic factor 5 
MyoD Myogenic differentiation 
NFκB Nuclear factor kappa-light-chain-enhancer of activated B cells 
NP-40 Nonidet P-40 
NSC neural stem cell 
P300 E1A binding protein p300  
Pax3 Pair box transcription factor 3 
Pax7 Pair box transcription factor 7 
PBS    Phosphate Buffered Saline 
PCAF  P300/CBP-associated factor 
PcG Polycomb-group 
PCR Polymerase chain reaction 
PenStrep Penicillin Streptomycin 
PFA Paraformaldehyde 
Pitx2 Pituitary homeobox 2 
PMSF Phenyl methyl sulfonyl fluoride 
Pol II RNA Polymerase II 
PRC2 Polycomb repressive complex 2 
PRMT5 Protein arginine methyl transferase 5 
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Prp8 pre-mRNA processing factor 8 
PR-Set7 PR/SET Domain-Containing Protein 7 
qPCR    quantitative PCR 
rDNA    Ribosomal DNA 
RNA Ribonucleic acid 
rpm Rotations per minute 
rRNA Ribosomal RNA 
RT Room temperature 
RT-qPCR Quantitative reverse transcription polymerase chain reaction 
s  Second 
SC Satellite cell 
SDS Sodium dodecyl sulfate 
SDS-PAGE  Sodium dodecyl sulfate polyacrylamide gel electrophoresis 
shRNA    Small hairpin RNA 
SILAC    Stable isotope labeling with amino acids in cell culture 
Srrm2 Serine/Arginine Repetitive Matrix 2 
SSC Saline-sodium citrate buffer 
STAT Signal transducer and activator of transcription 
SWI/SNF SWItch/Sucrose Non Fermentable 
T Thymine 
TA Tibialis anterior 
TBS Tris-Buffered Saline 
Tbx1 T-box transcription factor 1  
TES Transcription end site 
TFBS Transcription factor binding sites  
TrxG Trithorax group 
TSS Transcription start site 
Tween 20 Polyoxyethylene-sorbitan-monolaurate 
V Volt 
WT Wild type 
YFP Yellow fluorescent protein 
μg micro gram 
μl micro liter 
μM micro molar 
μm micro meter 
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Figure 5.6.5 Genetic ablation of p21 gene partially restores the proliferation capability of PRMT5 
deficient satellite cells 
Figure 5.7 PRMT5 is dispensable for embryonic Pax7+ muscle progenitor cell proliferation and 
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Figure 5.12 mRNA splicing factors are identified as PR-Set7 interaction partners by SILAC assay. 
Figure 6 Model depicting distinct genetic requirement for PRMT5 in control of fetal myogenesis and 
regenerative myogenesis 
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